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Abstract 
Understanding transcriptional regulation in development and disease is one of 
the central questions in modern biology. The current working model is that 
Transcription Factors (TFs) combinatorially bind to specific regions of the genome and 
drive the expression of groups of genes in a cell-type specific fashion. In organisms with 
large genomes, particularly mammals, TFs bind to enhancer regions that are often 
several kilobases away from the genes they regulate, which makes identifying the 
regulators of gene expression difficult. In order to overcome these obstacles and uncover 
transcriptional regulatory networks, we used an approach combining expression 
profiling and genome-wide identification of enhancers followed by motif analysis. 
Further, we applied these approaches to uncover the TFs important in mammalian sex 
determination. 
Using expression data from a panel of 19 human cell lines we identified genes 
showing patterns of cell-type specific up-regulation, down-regulation and constitutive 
expression. We then utilized matched DNase-seq data to assign DNase Hypersensitivity 
Sites (DHSs) to each gene based on proximity. These DHSs were scanned for matches to 
motifs and compiled to generate scores reflecting the presence of TF binding sites 
(TFBSs) in each gene’s putative regulatory regions. We used a sparse logistic regression 
classifier to classify differentially regulated groups of genes. Comparing our approach to 
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proximal promoter regions, we discovered that using sequence features in regions of 
open chromatin provided significant performance improvement. Crucially, we 
discovered both known and novel regulators of gene expression in different cell types. 
For some of these TFs, we found cell-type specific footprints indicating direct binding to 
their cognate motifs. 
The mammalian gonad is an excellent system to study cell fate determination 
processes and the dynamic regulation orchestrated by TFs in development. At 
embryonic day (E) 10.5, the bipotential gonad initiates either testis development in XY 
embryos, or ovarian development in XX embryos. Genetic studies over the last 3 
decades have revealed about 30 genes important in this process, but there are still 
significant gaps in our understanding. Specifically, we do not know the network of TFs 
and their specific combinations that cause the rapid changes in gene expression 
observed during gonadal fate commitment. Further, more than half the cases of human 
sex reversal are as yet unexplained.  
To apply the methods we developed to identify regulators of gene expression to 
the gonad, we took two approaches. First, we carried out a careful dissection of the 
transcriptional dynamics during gonad differentiation in the critical window between 
E11.0 and E12.0. We profiled the transcriptome at 6 equally spaced time points and 
developed a Hidden Markov Model to reveal the cascades of transcription that drive the 
differentiation of the gonad. Further, we discovered that while the ovary maintains its 
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transcriptional state at this early stage, concurrent up- and down-regulation of hundreds 
of genes are orchestrated by the testis pathway. Further, we compared two different 
strains of mice with differential susceptibility to XY male-to-female sex reversal. This 
analysis revealed that in the C57BL/6J strain, the male pathway is delayed by ~5 hours, 
likely explaining the increased susceptibility to sex reversal in this strain. Finally, we 
validated the function of Lmo4, a transcriptional co-factor up-regulated in XY gonads at 
E11.6 in both strains. RNAi mediated knockdown of Lmo4 in primary gonadal cells led 
to the down-regulation of male pathway genes including key regulators such as Sox9 
and Fgf9.  
To find the enhancers in the XY gonad, we conducted DNase-seq in E13.5 XY 
supporting cells.  In addition, we conducted ChIP-seq for H3K27ac, a mark correlated 
with active enhancer activity. Further, we conducted motif analysis to reveal novel 
regulators of sex determination. Our work is an important step towards combining 
expression and chromatin profiling data to assemble transcriptional networks and is 
applicable to several systems. 
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1. Introduction  
1.1 Transcriptional Gene Regulation  
Since the advent of molecular biology in the mid 20th century, one of the central 
questions and major thrusts of research has been to understand the mechanisms of how 
cells achieve the widely varying and dynamic profiles of mRNA expression that are 
observed in a plethora of situations including response to the environment, embryonic 
development, and disease states. Our understanding of this fundamental process has 
advanced by leaps and bounds in the last few decades. Before delving into our modern 
day conception of the players involved in transcriptional regulation, it is illuminating to 
briefly consider a historical view of how this understanding has evolved in the recent 
past. 
Groundbreaking work in understanding that non-coding DNA was important in 
directing gene expression came from work done in bacteria by Francois Jacob, Jacques 
Monod and Arthur Pardee (Darnell 2011). Specifically, by using bacterial genetics, they 
found operator sites, now known as Transcription Factor Binding Sites (TFBSs) that 
were bound by proteins, now known as Transcription Factors (TFs) to repress gene 
expression. These experiments opened the door to a major avenue into how organisms 
use a fixed genome to produce varied behaviors. Following this work, the recognition of 
the crucial role of messenger RNA (mRNA), and the identification of RNA polymerases, 
a key step came when the proteins responsible for repression were purified (Gilbert and 
Muller-Hill 1966; Ptashne 1967). Crucially, it was discovered that in these bacterial 
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systems, both activators and repressors act on gene regulation by interfering with the 
binding or interaction between RNA polymerase and other proteins that were part of the 
transcriptional machinery.  
 The situation in eukaryotic cells turned out to be far more complex. Using the 
technique of in vitro or cell-free transcription, it was discovered that in addition to RNA 
polymerase II, the enzyme responsible for mRNA transcription, a large cohort of 
additional proteins were required to transcribe genes. These ~30 factors are termed 
General Transcription Factors (GTFs), and are part of the machinery necessary for the 
production of mRNA in eukaryotic cells (Hampsey 1998). However, since these proteins 
are ubiquitously expressed, the question of how cell-type specificity of expression was 
achieved remained open. 
A key advance into this question came with the identification of distal regulatory 
regions called enhancer regions (Banerji et al. 1981). Discovered from SV40 viral DNA, 
these sequences were shown to drive high levels of transcription regardless of their 
orientation and at distances several kb from the Transcription Start Sites (TSSs) of genes. 
Following this, regions upstream of cell-type expressed genes were transfected into 
different cell lines. Crucially, some of these regions drove expression only in the same 
cell types as the downstream genes were expressed in. For example, a region upstream 
of the insulin gene drove expression specifically in a pancreatic cancer cell line (Walker 
et al. 1983). These sequences where then used to purify the proteins that bound to them, 
revealing transcriptional activators and repressors.  
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With this historical background, I will provide the modern conception of 
transcriptional regulation, particularly in mammals, with a focus on identifying the 
major players and their means of action. 
 
1.1.1 The role of transcription factors in gene regulation 
As mentioned, the primacy of TFs in gene regulation has long been recognized 
since their identification in the 1960s. Recent research has only solidified their status in 
establishing cellular states. A good example of the importance of TFs in orchestrating 
programs of gene expression is demonstrated by the ability of ectopically expressed TFs 
to reprogram fibroblasts into induced pluripotent stem cells (Takahashi and Yamanaka 
2006; Yu et al. 2007).  
TFs influence gene expression by binding to cis-regulatory elements, typically 
between 6-20 bp, that are present in the proximal promoter or in distal regulatory 
regions (Vavouri and Elgar 2005). Once TFs bind to their specific sites, they carry out 
several functions that have significant consequences for the genes that they regulate. A 
few of the mechanisms of action include directly recruiting PolII to the TSS (Boehm et al. 
2003), promoting the elongation of paused PolII (Kanazawa et al. 2003; Rahl et al. 2010), 
recruiting chromatin modifiers to the locus (Chen and Dent 2014), facilitating looping of 
distal regulatory regions to the promoter (Deng et al. 2012) and shuttling loci to distinct 
regions in the nucleus (Schoenfelder et al. 2010; Kohwi et al. 2013). Through a 
combination of several of these actions they either activate or repress downstream genes 
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leading to the elaborate spatial and temporal patterns of gene expression observed in 
development and response to environmental stimuli.  
How TFs find their targets in the genome has been a subject of intense research. 
Especially in mammalian organisms, across the genome, there are several hundreds of 
thousands of matches to the motifs that TFs bind to. However, genome localization of 
these proteins has revealed that they only bind to a fraction of these sites in vivo. Further, 
it is observed that the same TFs can bind to different subsets of TFBSs across different 
cell types (Lodato et al. 2013).  
A major determinant of which TFBSs are bound by a TF is the accessibility of the 
sites to the protein (Elnitski et al. 2006). Specifically, nucleosomes can act as a barrier to 
the binding of a TF to a region of the genome. One technique to assay the accessibility of 
different regions of the genome is DNase-seq (Boyle et al. 2008a). In this assay, nuclei are 
isolated and then the enzyme DNaseI is used to cut DNA at regions of the genome not 
bound by nucleosomes. The regions of the genome cut by DNaseI are bound by other 
proteins, including TFs, general TFs and the PolII initiation complex. Reads from these 
cuts are then sequenced, aligned to the genome and accessible regions or regions of open 
chromatin are identified (Song et al. 2011). For example, this technique was applied to 
identify what determined the binding sites of the Glucocorticoid receptor (GR) (John et 
al. 2011). The authors used DNase-seq to map the regions of open chromatin in an 
adenocarcinoma cell line prior to the treatment with a steroid hormone. Upon 
stimulation with a steroid hormone, the GR is activated and binds to >8000 genomic loci. 
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Crucially, over 90% of these binding sites are in regions that are accessible prior to 
stimulation. This implies that accessibility to chromatin is a determinant of which TFBSs 
among the several hundred thousand across the genome are actually bound by TFs.  
This observation then begs the question as to why certain regions are accessible 
and other regions are closed. One explanatory factor, in addition to the sequence 
preferences of nucleosomes (Kaplan et al. 2009), is a subset of TFs known as pioneer 
factors (Zaret and Carroll 2011). These pioneer factors have the unique ability across TFs 
to bind to their cognate binding sites despite a closed chromatin conformation. 
Therefore, these TFs bind to their targets even in a closed conformation and open up the 
neighboring regions allowing other TFs to access their cognate TFBSs. It is important to 
note that, despite their ability to bind regions that are inaccessible to other TFs, pioneer 
factors still only bind a subset of all their sites in the genome. This indicates that there 
are still other factors that regulate the selection of binding sites by pioneer TFs. 
Interestingly, these factors might themselves be chromatin modifications such as 
H3K9me3 that have been deposited on specific regions on the genome along the 
developmental lineage of the cell (Soufi et al. 2012).  
 
1.1.2 The role and identification of distal enhancers in gene regulation  
To regulate the expression of genes, TFs typically bind in dense clusters in distal 
regulatory regions known as enhancers (Bulger and Groudine 2011; Ong and Corces 
2011; Buecker and Wysocka 2012). Enhancers have been called the ‘information 
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integration hubs’ that consolidate environmental and developmental cues to produce 
different patterns of gene expression (Buecker and Wysocka 2012). These regions that 
are typically a few hundred base pairs in length are observed to be, particularly in 
mammals, at significant distances from the promoter of the gene that they regulate. In 
some extreme cases, the enhancer can be an Mb away from the gene or even on a 
different chromosome (Lettice et al. 2003). Recent work in Genome Wide Association 
Studies linking loci to diseases have revealed that 88% (Hindorff et al. 2009) of disease 
causing variants lie in non-coding regions of the genome, particularly in enhancers, 
stressing the importance of identifying and understanding the mechanistic functions of 
these enhancers (Cowper-Sal lari et al. 2012). 
An immediate question that arises is how these distal enhancers influence the 
transcription of the genes they interact with. Several models have been proposed from 
observations in different model systems (Ptashne 1986). For example, in the tracking 
model, regulatory proteins at the enhancer recruit PolII and other initiation factors 
which then slide along the DNA to find the promoter of the gene they regulate. In more 
recent literature, the model that has received a preponderance of support is the looping 
model. In this model, proteins bound at the enhancers interact with those bound at the 
promoter and thereby influence the expression of the gene. In one example, tethering a 
co-factor involved in the looping of an enhancer to a gene was sufficient to recruit PolII 
and to initiate the transcription of the gene (Deng et al. 2012). While this is an important 
step to understanding the mechanistic functions of enhancers, answers to the key 
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question of what is mechanistically achieved by the act of looping enhancers to 
promoters still remain preliminary (Krivega and Dean 2012). 
Given the importance of enhancers in regulating gene expression, significant 
research has gone into methods for identifying these regions. As mentioned above, these 
regions are a few hundred base pairs and can be several kb away from the genes they 
regulate. This makes their identification in the large non-coding genomic space 
problematic  (Haeussler and Joly 2011). One attempt to identify these regions, which has 
been possible with the sequencing of the genomes of several species, has been to look for 
conserved regions of non-coding sequence (Pennacchio et al. 2006). However, there are 
two significant drawbacks with this approach. First, it has been noticed that several 
enhancers which have functional impacts on driving the expression of downstream 
genes, nonetheless are not conserved (Blow et al. 2010). This implies that one cannot 
assume that the lack of sequence conservation implies that a region is not functionally 
relevant in driving expression. Second, even when enhancers are identified by looking at 
their sequence conservation, there are no clues as to when and in what condition these 
regions drive gene expression, which makes functional validation of predictions 
difficult.  
Other computational techniques attempt to identify enhancers by looking for 
sequence similarity across a set of known enhancers that drive a specific pattern of gene 
expression. These are then used to predict, in a genome-wide fashion, the location of 
other enhancers that are likely to drive similar patterns of gene expression (Kantorovitz 
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et al. 2009). For example, these methods have been successful in discovering enhancers 
that are active in Drosophila development. However, this approach is contingent on 
having a relatively large set of well characterized enhancers for the specific pattern of 
expression that one is interested in. Further, these methods have been shown to have a 
far lower efficacy in successfully predicting enhancers in the large non-coding genomic 
regions such as those found in mammals. 
An experimental approach to identifying enhancers is to conduct ChIP-seq 
assays for TFs that are known to be important in the differentiation of the cell type in 
question (Chen et al. 2008; Wilson et al. 2010; Tijssen et al. 2011). While individual TFs 
seem to only weakly predict the regulation of the genes adjacent to which they bind, the 
clustered binding of TFs has been seen to correlate with active enhancer activity. 
Crucially, this approach reveals the enhancers that are relevant to the gene expression 
observed in the specific cell type. Nonetheless, this approach requires one to know the 
TFs involved, have antibodies that are of ChIP grade quality and sufficient biological 
material to conduct these assays. In several developmental contexts, these prerequisites 
cannot be met.  
The alternative approach that has gained widespread use across a range of 
biological systems is to conduct genome-wide profiling to map some combination of 
chromatin modifiers (e.g. P300) (Visel et al. 2009), mediator subunits (e.g. Med1) (Whyte 
et al. 2013), chromatin accessibility (DNase-seq or FAIRE-seq) (Xu et al. 2012; McKay and 
Lieb 2013), chromatin modifications (H3K4me1 or H3K27ac) (Creyghton et al. 2010; 
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Rada-Iglesias et al. 2011; Rada-Iglesias et al. 2012; Nord et al. 2013; Visel et al. 2013) or  
enhancer RNAs (Kim et al. 2010; Andersson et al. 2014). Compared to other methods, a 
significantly larger proportion of enhancers identified by these methods have been 
shown to accurately drive cell-type specific expression. Importantly, since one only 
needs to profile a few features correlated with enhancers, this approach also requires 
less biological material than mapping the location of several TFs. However, it is 
important to recognize that while these features are highly correlated with enhancers, 
this does not imply causation (Henikoff and Shilatifard 2011). While factors such as 
Med1 and P300 are implicated in enhancer function with significant mechanistic basis, 
the roles, if any, of chromatin modifications still remain to be discovered. 
 
1.1.3 Building predictive models of gene expression 
Building predictive models of gene expression has been the focus of significant 
research. The general approach used is to first identify cell-type specific or temporal 
patterns of expression that need to be explained. Following this, putative regulatory 
regions for each gene are identified and scanned for sequence motifs. These sequence 
features are then used to build predictive models to differentiate the various patterns of 
expression for different classes of genes. These models are useful for two reasons. First, 
the performance of these models in predicting different classes of expression allows us 
to know whether our current understanding of how gene expression is regulated is 
sufficient to explain the behavior observed. Second, these models can identify specific 
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sequence features that are predictive. This is particularly useful as it can be used to 
generate hypotheses regarding the regulators that might bind to these sequence features. 
These can then be perturbed and gene expression of downstream genes monitored to 
expedite the process of discovering new regulators of gene expression in the system in 
question.  
Due to the inability to identify distal regulatory regions, early approaches 
concentrated on using the sequence around the promoter region to predict the 
expression of genes (Wasserman and Fickett 1998). This approach met with some 
success in organisms with smaller genomes such as yeast and even organisms such as 
Drosophila (Beer and Tavazoie 2004; Segal et al. 2008). Early attempts in mammalian 
organisms with this approach revealed that cell-type specifically expressed genes have 
lower CG content in their promoters compared to housekeeping genes (Lercher et al. 
2003). Further, while there are a few examples where sequence features in promoters can 
help predict genes that are cell-type specifically expressed (muscle and liver, for 
example) this approach has met with only limited success.  
The key to improving these models likely lies in being able to identify distal 
regulatory elements and identify the TFs bound in these regions to predict gene 
expression. In fact, using the ChIP-seq data sets available for a dozen TFs in ES cells, 
Ouyang et al. showed that not only could they predict relative expression levels, but also 
absolute expression levels (Ouyang et al. 2009). However, for reasons mentioned above, 
collecting TF ChIP-seq data for several factors is not feasible in most biological contexts. 
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As a result, there is a need to combine the approach of building predictive models from 
sequence features with the genome-wide identification of enhancers using marks 
correlated with cell-type specific enhancers.  
One other approach to build models that has significant predictive power bears 
mentioning.  These models use ChIP-seq data for histone marks around the promoter 
which are shown to be highly correlated with gene expression patterns and are 
extremely useful for predicting gene expression (Karlic et al. 2010). However, as 
mentioned previously, it is important to keep in mind that the correlative or causative 
impact of histone marks is a question that is yet to be resolved. In fact, some histone 
marks are a consequence of transcription as opposed to a means to regulate transcription 
(Henikoff and Shilatifard 2011). Further, in the few cases where the mechanistic 
consequences of histone marks have been studied, the results have been quite 
unexpected (Margaritis et al. 2012; Venkatesh et al. 2012). As a result, in the work 
presented in this thesis, we did not consider comparisons to models of gene expression 
built from ChIP-seq for histone marks. 
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1.2 Mammalian sex determination 
The differentiation of the gonad is an excellent system to study the principles 
underlying cell fate determination and the transcriptional programs that drive these 
processes. Given its central importance to the survival of species, a historical view of 
how our current conception has evolved is enriching. Therefore, I begin by surveying 
the key experiments leading to our current view of sex determination. Following this, I 
discuss the factors involved in the differentiation of the supporting cells in the gonad. 
1.2.1 A brief history of sex determination and differentiation 
 The differences in physiology between males and females of several species 
have in all likelihood always been noticed. Various explanations have been offered 
including astronomical signs such as the presence or absence of a halo around the moon 
during conception, and the ‘heat’ of the father in determining the sex of the child 
(Carlson 2013). While examples of this sort are numerous and often entertaining, the 
modern view of sex determination arose in the early 20th century. The prevailing belief 
around this time was that sex was determined by external environmental stimuli, such 
as nutrition, as opposed to internal genetic causes (Morgan 1903).  
The first hints that there was a genetic basis of sex determination came from the 
cytological work of Hermann Henking, Clarence McClung, Nettie Stevens and E. B. 
Wilson (Brush 1978). These experiments provided important correlative evidence of the 
presence and absence of specific chromosomes with being male and female. For 
example, using the mealworm beetle, Tenebrio Molitor, Nettie Stevens identified that 
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male mealworms made sperm with either 10 chromosomes of a large size or 9 large 
chromosomes and 1 small chromosome. Crucially, when she looked in the somatic cells 
of males and females, she found that females have 20 large chromosomes, while males 
have 19 large chromosomes and 1 small chromosome. She concluded that ‘this result 
suggests that there may be in many cases some intrinsic difference affecting sex’ 
(Stevens 1905). The large unpaired chromosome in males was later termed the X and the 
small chromosome, if present, was termed the Y chromosome. Shortly thereafter, 
Theophilus Painter conducted careful cytological work in human testicular tissue, 
discovering that humans too had a difference in their chromosomal complement 
between males and females (Painter 1923). Specifically, in males, he found one X and 
one Y chromosomes where females had two X chromosomes.  
These discoveries were significant in identifying the potential causes of sex 
determination in mammals and in other species. However, particularly in mammals, a 
key question remained regarding the role of the Y chromosome in sex determination. 
Two chromosomal abnormalities observed in human populations helped settle this 
question. First, it was shown that patients with Klinefelter syndrome, who display male 
sexual characteristics, have a 47, XXY karyotype (Jacobs and Strong 1959). Second, it was 
discovered that patients with Turner syndrome, who display female sexual 
development, have a 45,X karyotype (Ford et al. 1959). These results strongly confirmed 
that, in humans, the presence of a Y chromosome was a dominant determinant of male 
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sexual differentiation and the presence of a single X chromosome was sufficient for 
female development.  
While identifying the importance of the genetic underpinnings of sex 
determination, a key question remained untouched. Namely, does the organism make 
cell-autonomous decisions resulting in the various sexual differentiation characteristics 
or is there a specific organ that is primarily affected by the genetic difference that is then 
responsible for the sexual differentiation of the rest of the embryo?   
The key experiment in determining the causal role of the gonad and the 
hormones it produces in development was conducted by Alfred Jost in 1947 (Josso 2008). 
In a technically challenging experiment, Jost removed gonads from rabbits in utero and 
then allowed them to develop. He noted that, while the removal of gonads from female 
rabbits at any stage had no impact of the development of female characteristics, the 
removal of male gonads had a time-sensitive phenotype. Specifically, late removal of the 
gonads from male rabbits (day 23 onward) had no influence on the development of male 
characteristics. However, removing the gonad at earlier stages in male rabbits caused 
them to develop as phenotypical females. Later work showed that the two hormones 
produced by the testis that were instrumental in producing male sexual development 
were testosterone and Anti-Mullerian Hormone. This was a convincing argument that, 
in mammals, the gonad was the central organ involved in governing the sexual 
differentiation of the rest of the organism. 
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In sum, the modern view of sex determination and differentiation is as follows 
(Figure 1). Sexual development, in mammals, can be thought of as a hierarchy with three 
levels. Genetic sex is set at fertilization when an X-bearing egg is fertilized by an X- or Y- 
bearing sperm. In a process known as primary sex determination, this genetic difference 
leads to a difference in gonadal sex, i.e. the development of either an ovary in XX 
embryos, or a testis in XY embryos. The gonads then produce the hormones necessary to 
direct the sexual differentiation of the rest of the embryo.  
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Figure 1: Primary sex determination and secondary sex differentiation 
In mice, genetic sex is determined at fertilization by an X or a Y bearing sperm. In 
a process known as primary sex determination, this genetic difference governs the 
differentiation of the gonad to an ovary (XX) or a testis (XY). The gonads produce the 
hormones necessary for the sexually dimorphic differentiation of the rest of the mouse in 
a process known as secondary sex differentiation. Picture of mice are from (Bishop et al. 
2000). 
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Although the dominant role of the Y-chromosome in determining testis 
differentiation in mammals was made in 1960, it took 3 decades to identify the gene on 
the Y chromosome that was responsible for this behavior. After a few missteps, the 
transcription factor Sry was identified as the testis determining factor. The key data 
came from analyzing three XX individuals who had developed as males. These three 
individuals shared a 35kb region of the Y-chromosome in which the gene Sry was 
present (Gubbay et al. 1990). In addition, conservation across mammals, testis specific 
expression of this transcript and the generation of XY female mice confirmed that Sry 
was the causative gene (Koopman et al. 1990; Sinclair et al. 1990) in determining testis 
development.  
 
1.2.2 Differentiation of the supporting cells: The basis of primary sex 
determination 
In mice, the gonad forms as a thickening of the cells of the coelomic epithelium 
on the mesonephros around mid-gestation (~ embryonic day (E) 11.0) (Brennan and 
Capel 2004). Unlike any other organ, the gonad, at this stage, is bipotential - regardless 
of the genetic sex of the cells that comprise it, it can become a testis or an ovary. 
Interestingly, even prior to its differentiation at E11.0, it is comprised of multiple cell 
types including the supporting cells, interstitial cells, endothelial cells and the germ 
cells. The first cell type to differentiate in XY and XX gonads are the supporting cells. 
Upon differentiation, these cells provide the signals for the differentiation of the other 
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cells in the gonad. Therefore, the initial key steps of gonadal differentiation are carried 
out in the supporting cells. 
In murine XY gonads, the TF Sry, is transiently expressed between E10.5 and 
E12.0 and binds to the testis specific enhancer region of another TF on an autosomal 
chromosome, Sox9 (Gubbay et al. 1990; Lovell-Badge and Robertson 1990; Vidal et al. 
2001; Sekido et al. 2004). The resulting up-regulation of Sox9 is sufficient for testis 
differentiation and obviates the need for the expression of Sry. It is important to note 
that there is a critical window for the activation of the male pathway. In a particularly 
illuminating experiment, Hiramatsu et al. used transgenic mice that had an Hsp-Sry 
construct to initiate the male pathway at specified time points (Hiramatsu et al. 2009). 
Interestingly, there was a 6hr interval between E11.0 and E11.25 where Sry expression 
had to occur for testis development to be initiated. If this interval was missed, while 
Sox9 could be activated, the targets downstream of Sox9 remained at expression levels 
observed in the ovary. Indeed, the role of the timing and level of Sry activation has been 
suggested to be involved in sex reversals observed in the case of weak Sry alleles.  
An important target of Sox9 is the signaling ligand Fgf9 which binds to its 
receptor Fgfr2 (Kim et al. 2007). This signaling pathway is an important component that 
reinforces the fate commitment decision by repressing the alternative ovarian pathway 
and maintaining the expression of Sox9 (Colvin et al. 2001; Kim et al. 2006). In XX 
gonads, the signaling ligand Wnt4 has a central role in directing the ovarian pathway 
partly through the stabilization of beta-catenin (Ctnnb1) (Vainio et al. 1999). Crucially, 
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stabilization of Ctnnb1 results in antagonism of the male pathway and the development 
of XY gonads to ovaries (Maatouk et al. 2008).  It is also important to note that the two 
signaling pathways that promote the testis and ovarian fate are mutually antagonistic 
(Kim et al. 2006; Kim et al. 2007; Jameson et al. 2012a). Specifically, on a background 
susceptible to sex reversal, disruption of FGF signaling, results in XY embryos forming 
ovaries (Colvin et al. 2001). However, when WNT signaling is also inhibited, the 
phenotype is rescued and XY embryos develop testis (Jameson et al. 2012a). This 
indicates that the feedback interaction of FGF signaling on Sox9 expression is likely 
enacted through the repression of WNT signaling, which itself is repressing Sox9 
expression.  
In addition to these genes, genetic experiments have revealed approximately 30 
other genes to be involved in the sex determination decision. Specifically, TFs such as 
Nr5a1, Wt1, Emx2 and Lhx9 are involved in the initial development of the bipotential 
gonad (Eggers and Sinclair 2012). Further, a host of other TFs, co-factors and chromatin 
modifiers are involved in the differentiation pathways of the testis and ovary (Figure 2). 
These genes are involved in the dynamic regulation of several hundreds of genes that 
are differentially expressed between testis and ovaries. Key questions remain regarding 
how this is accomplished. 
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Figure 2: The network in supporting cells 
Several genes involved in the differentiation of the bipotential supporting cell 
pre-cursors to Sertoli cells in the testis and Granulosa cells in the ovary. Transcription 
factors and co-factors are shown in bold on either side of the figure and signaling 
molecules are shown on the right of the figure. The basic genetic network driving sex 
determination is shown in the middle. Sry activates Sox9 which along with Fgf9 governs 
the differentiation of the Sertoli cells. While the trigger of ovarian development is as yet 
unknown, Wnt4, Rspo1 and Foxl2 are known to be important in governing Granulosa cell 
differentiation. FGF and WNT signaling also mutually antagonize each other. 
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Despite identifying several factors involved in primary sex determination 
(Eggers and Sinclair 2012), several lines of evidence indicate that our knowledge about 
this network is limited. First, more than half (50-75%) of the human cases of Disorders of 
Sexual Development (DSDs) are unexplained by mutations in known genes or their 
regulatory regions. Second, even though we have identified several key regulators, 
barring a few exceptions (De Santa Barbara et al. 1998; Wilhelm et al. 2007; Bradford et 
al. 2009), we are unaware of the targets of their regulation. Importantly, gene expression 
profiling of the gonads done by the Capel lab and others reveal that there are large 
cohorts of differentially expressed genes soon after the onset of gonadal differentiation 
(Nef et al. 2005; Munger et al. 2009).  
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1.3 How to assemble a network of sex determination 
 To build a predictive model of transcriptional regulation, one can approach the 
problem as follows. First, the transcriptional behaviors have to be characterized. This 
would include trying to identify patterns of up- and down-regulation and of expression 
patterns that do not show variation between conditions. Second, given the importance of 
TFs in transcriptional regulation, one can use the expression data to identify TFs that 
also show patterns of differential expression. Third, especially in mammalian organisms, 
one needs to be able to identify the distal regulatory regions where TFs bind. Finally, the 
combination of all this information can be used to build predictive models of expression 
to understand the roles played by the TFs in the expression patterns observed.  
This was precisely the approach we took in using data from 19 human cell lines 
from diverse origins for which we had DNase-seq data identifying putative regulatory 
regions and matched expression data from Affymetrix microarrays (Natarajan et al. 
2012). We then used this information to identify sequence features that predict the 
expression patterns we observed across these diverse cell lines. 
 In applying this method to understanding gonadal differentiation, our first step 
was to carefully analyze the global changes to the transcriptome during the critical 
window of sex determination (Munger et al. 2013). By observing XX and XY gonads 
from two different inbred strains of mice, we were able to identify cascades of 
differential expression that occurred as the bipotential gonad committed to its testicular 
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or ovarian fate choice. These cascades of expression suggested hypotheses regarding the 
important TFs in mammalian sex determination.  
 In order to identify enhancers in a genome-wide fashion in the supporting cells 
in the gonad, we performed DNase-seq and ChIP-seq for histone marks correlated with 
active enhancers. We then analyzed these putative regulatory regions to identify the TFs 
that were bound to these regions. 
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2. Materials & Methods  
2.1 Predicting cell-type specific expression from regions of open 
chromatin 
2.1.1 DNase-seq 
DNase-seq was performed on 19 human cell lines representing a wide variety of 
tissue types, and aligned reads were used to define DNase hypersensitive sites (DHS). 
Data from 7 cell lines were previously published (Song et al. 2011), and remaining 
libraries were processed as described in that study. Reads generated were aligned to the 
hg19 genome using BWA and were then smoothed using a kernel density estimator, f-
Seq (Boyle et al. 2008b; Li and Durbin 2009). Following this, DHS peaks were identified 
as having a -log10(p-value) >= 1.3. We refer to these regions as DHS or regions of open 
chromatin. Note that the AoSMC cell line was in serum free media. 
 
2.1.2 Classifying DHS based on genomic location 
The Refseq hg19 database was downloaded from the UCSC genome browser and 
used to classify DHS based on their genomic location. If a DHS overlapped the TSS of 
any transcript variant of a gene it was classified as being a TSS DHS for that gene. Other 
DHS were similarly classified as Gene Body DHS if they overlapped any region of the 
gene excluding the TSS. All other DHS were classified as Intergenic DHS. 
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2.1.3 Microarrays 
We used Affymetrix Human Exon 1.0ST microarrays to measure gene expression 
following ENCODE protocols. We normalized 110 microarrays (measuring 40 cell lines) 
together, then extracted the subset (19 cell lines) used in the present study. Probesets 
flagged as cross-hybridizing were first removed from the analysis (Salomonis et al. 
2010). Though these arrays provide exon-level probesets, we sought gene-level 
expression estimates, so we grouped probesets by gene for normalization (Bemmo et al. 
2008). To normalize, we used Affymetrix Power Tools (APT) with the chipstream 
command ‚rma-bg, med-norm, pm-gcbg, med-polish‛. This chipstream calls for an 
RMA normalization with gc-background correction using antigenomic background 
probes. After normalizing, we noticed an effect due to a switch in microarray reagents. 
Some of our arrays were processed differently, because our earlier array reagents 
become unavailable partway through the experiment. Using hierarchical clustering and 
multidimensional scaling, we found the arrays to group on the basis of reagent used, 
rather than by biological relatedness. To make the arrays comparable, we used an R 
script (ComBat) to correct for this batch affect (Johnson et al. 2007). After correction with 
ComBat, the arrays grouped according to expected biological similarity. 
 
2.1.4 Cell-type specific expression 
We identified the genomic location of genes based on matching gene symbols to 
the refseq hg19 database. If a gene from the array did not have a matching gene symbol, 
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it was dropped from the analysis. If a gene did not have expression above background (> 
4.8) in at least one cell type it was dropped from the analysis. For remaining genes, 
expression values across the 19 cell lines were z-transformed. The z-scores for expression 
in each cell line were sorted. The top 200 genes were classified as UR genes, and the 
bottom 200 genes as DR genes in that cell type. For each cell type, the UR-Other genes 
were compiled as follows. We first made a set comprising all UR genes from all cell 
types. We then removed the current cell type UR genes from this global UR gene set. We 
further removed genes from this set that had expression z-score >= 0 in the current cell 
type to exclude genes that had higher than mean expression in that cell type. This 
ensured that this set of genes was purely comprised of genes that were up-regulated in 
other cell types and had lower than mean expression in the current cell type. A similar 
procedure identified DR-Other genes. To identify constitutively expressed genes, we 
selected genes in either UR or DR sets across all cell lines, were expressed above 
background in all cell lines and had a maximum |z-score| < 1.7 which resulted in 168 
genes. This size compared well to the other positive sets of UR and DR genes. This gave 
us a list of genes that did not have a significant variance in their expression.  
 
2.1.5 GO Analysis  
DAVID was used to identify functional categories of genes up-regulated in each 
cell type (Huang et al. 2009a; Huang et al. 2009b).We used the GO categories and also 
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the UP_Tissue category to identify the tissue showing the closest gene expression profile 
to the cell type in question. p-value <0.05 was used as the significance threshold. 
 
2.1.6 PWM scans of DHS and promoter sequences 
We collected PWMs for vertebrate TFs from the Transfac, JASPAR and UniProbe 
databases. This gave us a collection of 789 PWMs some of which refer to the same TF. 
Note that we allowed multiple PWMs for each TF in our data set since it is generally not 
known which one reflects binding affinities more accurately. Furthermore, multiple 
PWMs may also reflect different binding modalities for the same factor. This could be 
due to, for example, the presence of specific cooperative binding partners in one cell 
type but not in another. 
We scanned the sequence from each DHS site and (proximal) promoter sequence 
(-900 to +100 relative to each TSS of a gene) using these PWMs. A score was assigned to 
each location in the sequence based on the log likelihood ratio of the PWM score 
(probability of the PWM generating the specific sequence) versus the probability that the 
sequence was generated by a background model. The background model used was a 
first-order Markov Model trained over a 500bp window centered at the base pair being 
scored. This effectively corrects for the underlying dinucleotide composition and allows 
us to separate signal from noise (Megraw et al. 2009). Scores with a log-likelihood ratio 
less than 0 were not included in further analysis. 
 28 
 
After these scores were generated for each base pair, we summed scores across a 
sliding window of size 60 bp to account for local clusters of multiple, potentially 
overlapping binding sites. Clusters of binding sites have been shown to be more likely to 
be bound by TFs as opposed to single binding sites (Gotea et al. 2010). For each DHS or 
promoter sequence, we assigned the maximum sliding window score as the TFBS score 
for that TF for that sequence. 
 
2.1.7 Associating DHS TFBS scores with genes 
To associate each DHS with a gene that it was potentially regulating, we found 
the closest TSS to the midpoint of the DHS. The DHS was then associated to that gene. In 
general, there were several associated DHS for each gene, and these were assumed to be 
the putative regulatory regions for that gene. To assign one score for a TFBS to each 
gene, we picked the maximum TFBS score across all the associated DHS (closest gene 
DHS). In Split DHS, we separated DHS into two groups - overlapping TSSs and those in 
other parts of the genome. We selected the maximum from both sets, therefore having 
two features per gene per TF. 
 
2.1.8 Sparse Logistic Regression Classifier 
We used a sparse logistic regression classifier that minimizes an objective 
function which is a linear combination of the sum of squared residuals and the l1-norm 
of the weights (Koh et al. 2007).  We divided our data into 4 parts to perform a 4-fold 
 29 
 
cross validation. 3 parts of the divided data were used as the training set. This training 
set was further divided into 6 parts, 1 of which used as the validation set to learn the 
hyperparameter for the contribution of the l1-norm in the objective function. The 
optimal hyperparameter was selected from 10 values (0.001, 0.011 . . . 0.091). This value 
was then used to evaluate the performance of the model on the original test set, and the 
area under the receiver operating characteristics (AuROC) was computed as a measure 
of performance. We performed 5 iterations of each 4-fold cross validation, with the data 
shuffled before each iteration. Results for each classification task are therefore averages 
over 20 different partitions of the data, which makes our result more robust to chance 
arrangements of the data. 
 
2.1.9 Cell-type specific expressed non-redundant TFs 
To identify TFs that were cell-type specifically expressed, we used the absolute z-
score and extracted gene symbols for TFs with available PWMs. We again used the gene 
symbol from the Affymetrix arrays to match expression to TF names in our PWM list. By 
using absolute z-score we picked out genes that were cell-type specifically up- and 
down-regulated. To ensure that we were picking a non-redundant set of TFs, we used 
STAMP (Mahony and Benos 2007) with the default settings. Starting from the TF with 
the highest absolute z-score we only added a TF when it had a significantly different 
PWM (e-value > 0.25) from the TFs already chosen. We stopped adding to the set when 
we had 10 TFs.  
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2.1.10 Conservation analysis 
Genomic regions from the 46 way placental mammal track were downloaded 
from UCSC genome browser. Only regions of size 100bp or more were used. Coding 
exon sequences were extracted from the refseq hg19 database. BedTools (Quinlan and 
Hall 2010) was used to subtract exonic coding sequences from conserved regions to find 
non-coding conserved regions. Regions were scanned for motifs and TFBS scores 
assigned to genes in the same way as open chromatin regions. 
 
2.1.11 Discriminative Motif finding using MEME 
We used MEME to first calculate a position-specific prior using the psp-gen tool. 
For example, if we wanted to identify the motifs in the DHS sequences related to the UR 
genes when classifying against DR genes, the positive file was the UR genes and 
negative file was the DR genes. This was then used to identify motifs from a 1000 
positive sequences, UR gene DHS sequences in the above example. The motif width was 
chosen to be between 8-12 bp and motifs were allowed to have zero or one occurrence 
per sequence. Motifs with an e-value below 0.05 were then compared to either the top10 
non-redundantly expressed TFs or the full list of TFs using STAMP. A STAMP e-value 
less than 0.05 was accepted as a good match of a motif to TF.  
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2.1.12 ChIP analysis 
ChIP-seq peak coordinates were obtained from ENCODE webpage in BED 
(narrowPeaks) file format. To assess whether DHS are really bound by the TF or not, we 
checked for overlap between the coordinates of DHS and ChIP-seq peaks for that TF. To 
calculate AuROC, the TFBS scores in the DHS were compared against  ChIP-seq peaks. 
Overlaps with the 60 bp window around the TFBS site were considered true positives 
and others were considered false positives for AuROC calculations.  
 
2.1.13 Footprinting Analysis 
DNase reads were used to plot the distribution of DNase-seq reads around 
transcription factor binding sites. Number of reads mapping to 100 base pairs 
surrounding transcription factor binding sites were counted for each site and aggregated 
over the 10,000 highest scoring binding sites. A trough centered at the binding sites in 
such plots is called a DNase footprint, indicative of protection of the binding site against 
DNase digestion by a bound TF. 
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2.2 Fine time-course expression analysis 
2.2.1 Mice, dissection, developmental staging, and genotyping 
For the time course microarray study, C57BL/6J (stock no. 000664) and 
129S1/SvImJ (stock no. 002448) mice were obtained from The Jackson Laboratory. CD-1 
outbred mice were used (strain code 022, Charles River) in the gonad primary cell 
assays.  
Timed matings were established for B6 and 129S1, and embryos were collected 
from dams between embryonic day (E) 11.0-12.0. Embryos were individually staged by 
counting tail somites (ts) distal to the hindlimbs: E11.0, E11.2, E11.4, E11.6, E11.8, and 
E12.0 correspond to 13, 15, 17, 19, 21, and 23 ts, respectively (Munger et al. 2009; Michell 
et al. 2010). For each strain at each time point, three individual pairs of XX and XY 
gonads from at least two separate litters were collected. The chromosomal sex of each 
embryo was determined by PCR on head DNA using primers to detect Kdm5c/Kdm5d 
(5’-TGAAGCTTTTGGCTTTGAG-3’ and 5’-CCGCTGCCAAATTCTTTGG-3’). Gonads 
were dissected away from mesonephroi in sterile PBS (Gibco/Invitrogen, cat no. 1490-
144) and stored in RNAlater RNA stabilization solution (Ambion, cat no. AM7024) at -
20C until all samples were collected. To minimize contamination and RNA degradation, 
all surgical instruments and surfaces were treated with RNaseZAP RNase 
decontamination fluid (Ambion, cat no. AM9780), followed by 70% EtOH in DEPC-
treated water, before and during the dissection procedure. 
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2.2.2 Microarray Processing - RNA isolation, labeling, and 
hybridization 
For the microarray analyses, at least three biological replicate samples were 
profiled for each strain/stage/sex (n=74 total arrays), with one exception (n=2 replicates 
for 129S1 E12.0 XY). Total RNA was first extracted from individual pairs of E11.0-E12.0 
XX and XY gonads (separated from mesonephroi) with the RNeasy Micro kit with on-
column DNase digestion (QIAGEN, cat no. 74004) following the manufacturer’s 
protocol. Total RNA was eluted in 14 ul RNase-free water (not DEPC- treated), and 2 ul 
were used to quantify RNA concentration on a NanoDrop ND-2000 (Thermo Scientific). 
Only samples with > 100 ng of total RNA and an A280:A260 ratio of >1.6 were included 
in the expression analyses. 
From each total RNA sample, mRNA was selectively reverse transcribed with 
oligo(dT) primers to T7-labelled cDNA, and then amplified by in vitro transcription 
(IVT) to produce biotinylated cRNA using the Illumina TotalPrep Amplification Kit 
(Ambion/ Life Technologies, cat no. AMIL1791) according to manufacturer’s 
instructions.  cRNA concentration was quantified on the NanoDrop ND-2000, and 
individual samples were concentrated in a vacuum centrifuge as necessary. 750ng of 
biotinylated cRNA (in ~10 ul volume) were hybridized to Illumina MouseRef-8 v2.0 
BeadChips (Illumina, cat no. BD-202-0202) according to Illumina protocols, and array 
intensity was measured on an iScan scanner (Illumina). To minimize potential for batch 
effects to confound analysis, individual samples were assigned to 8-sample BeadChips 
using a balanced design. 
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2.2.3 Microarray data processing 
Microarray data files were imported into GenomeStudio software (Illumina, 
V2010.1), and raw expression values for each sample extracted. Expression values were 
quantile normalized and log2 transformed using the R package BeadArray (Ritchie et al. 
2011). Probes that had a detection p < 0.005 in at least two replicates for any sample type were 
used for analysis. Data will be publicly accessible on GEO upon acceptance of the manuscript. 
Data are publically accessible in GEO (accession number GSE41948). 
 
2.2.4 ANOVA analysis 
The ANOVA analysis was conducted using the R package Limma (Smyth 2004). 
A sex by strain by stage factorial analysis was conducted as outlined in (Smyth et al. 
2005). The model included the sex, strain, and stage variables, the sex*strain, sex*stage 
and strain*stage two-way interaction terms, and a three-way interaction term 
sex*strain*stage. The model was fit for all the probes that had reliable expression 
(detection p < 0.005) in at least two replicates of any one sample using the lmFit function 
in the Limma package. The statistical significance of each of the terms was evaluated 
using the eBayes function in Limma. Probes that did not have a significant difference 
(Benjamini-Hochberg adjusted p < 0.05) for at least one of the variables were excluded 
from further analysis.  
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2.2.5 HMM to identify dimorphic expression 
Hidden Markov Models (HMMs) are generative probabilistic models that 
explicitly model the observed data as being emitted by a ‘hidden’ biological state (here, 
male or female enrichment). Further, transition probabilities between states capture the 
time dependencies in data between adjacent time points. Inference algorithms allow for 
computing the most probable state paths that give rise to the observed data, and 
accounts for noise inherent in observed data. The modeling of time dependencies 
between biological states, and accounting for noisy observations, makes HMMs 
particularly well-suited to analyze time course microarray data (Schliep et al. 2003; Yuan 
and Kendziorski 2006). 
We designed a left-to-right HMM with three states per time point. The three 
states correspond to male state (with higher expression in males), female state (with 
higher expression in females) and similar expression state (with no difference in 
expression between the two sexes). The observed data on which the model was trained 
and clustered was the quantized Fold Difference (FD) of the log2 normalized values 
between XX and XY gonads at each time point. Note that a fold change of expression of 
1.25 corresponds to an FD of 0.3219, fold change of 1.5 to an FD of 0.585 and a fold 
change of 2 to an FD of 1. Limma was used to calculate FD between XX and XY gonads 
at each time point for each strain. If a specific comparison did not have a p-value <0.05, 
or |FD| > 0.3219 then the FD for that comparison was set to 0. The FD was then 
quantized into symbols as follows: 
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Symbol s - Similar expression in XX and XY gonads [-0.3219 < FD < 0.3219].  
Symbol m1 - Higher expression in XY gonads [0.3219 < FD < 0.5850]. 
Symbol m2 - Higher expression in XY gonads [0.5850 < FD < 1]. 
Symbol m3 - Higher expression in XY gonads [1 < FD] 
Symbol f1 - Higher expression in XX gonads  [0.3219 > FD > -0.5850]. 
Symbol f2 - Higher expression in XX gonads [0.5850 > FD > - 1]. 
Symbol f3 -  Higher expression in XX gonads [1 > FD]. 
The symbols m1, m2, m3, and f1, f2, f3 indicate varying levels of confidence in the 
differential expression between XX and XY gonads.  
For each gene, for each strain there were 6 symbols indicating the FD between 
XX and XY gonads across the time window. For example, for Sox9 in the 129S1 strain, 
the following FDs were observed at the 6 time points – 0, 0.77, 1.41, 2.41, 2.30, and 1.97. 
Following the rules listed above, this was quantized as s, m2, m3, m3, m3, m3.  
The emission probabilities of the HMM were initialized as shown in Figure S2B 
to reflect the intuitive meaning of the states and the possible observed symbols from 
each state. Note that all probabilities were initialized as being non-zero. After training 
was completed, emission probabilities still reflected the intuitive meaning of the states 
(Figure S2B). 
The transition probabilities between states were initialized as follows (Figure 
S2A). Observed symbols were first classified into male, female and similarly expressed – 
symbols m1, m2, m3 into state M, symbols f1, f2, f3 into state F, and symbol s to state S. 
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Transitions between all combinations of states in adjacent time points were counted and 
normalized to make transition probabilities from each node sum to 1. A pseudocount of 
1 was added to all possible transitions (transition between states in adjacent time points) 
to initialize all probabilities as non-zero.  
The HMM was trained using the Baum-Welch algorithm for 200 iterations with 
data from both strains for all the probes that passed the filtering criteria and were shown 
to have a significant effect for at least one variable in the ANOVA analysis. The state 
path for the observed FDs for each of the probes was computed using the Viterbi 
algorithm. Probes with the same state paths were clustered together. 
 
2.2.6 shRNA clones and lentivirus production 
Pre-validated gene-specific MISSION® shRNA clones (Sigma Aldrich; Sox9 
pLKO.1 clones: TRCN0000086165, TRCN0000086167; Lmo4 pLKO.1 clones: 
TRCN0000084373, TRCN0000084375; Non-targeting Controls – TurboGFP shRNA 
SHC004, eGFP shRNA SHC005) and lentiviral packaging and envelope plasmids 
(Addgene; pCMV-dR8.2 dvpr ID# 8455, pMD2.G ID# 12259) were purchased as bacterial  
stocks, and high quality plasmid DNA was isolated from overnight liquid LB cultures 
with a Maxiprep kit (QIAGEN, cat no. 12162) following manufacturer’s instructions and 
quantified on a NanoDrop ND-2000.   
Lentivirus production followed the Addgene 4-day protocol with slight 
modifications (www.addgene.org/tools/protocols/pLKO/) (Moffat et al. 2006). All work 
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with lentiviruses was performed in a BSL2+ hood following approved biosafety 
procedures. On Day 1, for each sample, 5x106 HEK-293T/17 cells (ATCC cat no. CRL-
11268) were suspended in 10 ml of Dulbecco’s Modified Eagle Medium (DMEM, Gibco 
cat no. 11995) + 10% Fetal Bovine Serum (FBS) without antibiotics, plated to 10 cm cell 
culture plates, and incubated at 37°C, 5% CO2 overnight. Late in the afternoon of Day 2, 
10 ug of pLKO.1 shRNA plasmid, 7.5 ug of pCMV-dR8.74 dvpr packaging plasmid, and 
2.5 ug of pMD2.G envelope plasmid DNA were suspended in Opti-mem serum-free 
medium with 60 ul X-tremeGENE HP DNA transfection reagent (Roche, cat no. 06 366 
236 001) in a 3:1 ratio to a total volume of 600 ul, incubated at 25°C for 20 minutes, then 
applied drop-wise to the 10 cm plate containing HEK-293T/17 cells at 60-80% 
confluency, swirled gently to disperse evenly but not dislodge cells from the plate, and 
incubated at 37°C, 5% CO2 overnight (12-18 hours). On day 3, media containing the 
transfection reagent was removed carefully and decontaminated in >10% bleach. Next, 
5.5 ml of fresh viral growth medium (vGM, containing Neurobasal medium (Gibco, cat 
no. 21103-049) supplemented with 10% FBS, 0.5 mM L-glutamine (Gibco, cat no. 25030-
149), and 1x Antibiotic-Antimycotic (Gibco cat no. 15240-062)) was added carefully to 
the side of the plate so as not to disturb the transfected virus-producing cells, and 
incubated at 37°C, 5% CO2 overnight. Late in the afternoon of day 4, the virus-containing 
vGM was harvested with a 10 ml syringe, and filtered through a 0.45 um PES syringe 
filter (Whatman, cat no. 6780-2504) into sterile 2.0 ml polypropylene cryo-vials. Viral 
media was stored at 4°C for use within 5 days, or at -80°C for long-term storage. All 
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laboratory materials that came into contact with viral particles were treated as 
biohazardous waste and autoclaved according to BSL2+ safety practices. 
 
2.2.7 Gonad Primary Cell Assays 
The effect of silencing candidate regulatory genes was assayed in dissociated 
gonad primary cell cultures. Timed matings were established for CD-1 mice, and 
embryos were collected from dams at E12.5. Gonads were dissected away from the 
attached mesonephroi, sexed by visual inspection for testis cords, and XY gonads from a 
litter were counted and pooled. Pooled XY gonads were then dissociated in 0.25% 
Trypsin-EDTA (1x, Gibco cat no. 25200-056) for 15 minutes at 37°C with slight agitation, 
followed by centrifugation at 4000 rpm for 5 minutes, washed once with DMEM (Gibco 
cat no. 11965) followed by centrifugation, and suspended in Opti-Mem (Gibco cat no. 
11058-021) supplemented with 1% FBS. Cells from one pair of XY gonads were 
determined to be sufficient for one well of a 24-well culture plate, and the amount of 
suspension liquid was calculated by multiplying 250 ul by the number of pairs of XY 
gonads in the pooled sample.  
Following the dissociation and wash steps, 250 ul gonad primary cells were 
immediately added to individual wells of a 24-well cell culture plate, and 250 ul of the 
appropriate lentivirus-containing vGM was added to each well in a BSL2+ hood. In 
addition to wells designated to assay target gene shRNA-mediated knockdown, separate 
wells containing XY gonad primary cells from the same litter were infected with the 
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non-targeting eGFP shRNA (SHC005) and/or TurboGFP shRNA (SHC004) controls. 
Plates were incubated at 37°C 5% CO2 for 68-72 hours and cell viability was monitored 
daily with a light microscope. Virus production could be monitored visually for the 
TurboGFP control infected cells using a fluorescence microscope. 
 
2.2.8 qRT-PCR 
Following 68-72 hours incubation, total RNA was isolated from shRNA 
lentivirus-infected gonad primary cells using Trizol reagent (Life Technologies, cat no. 
15596-018). Briefly, lentivirus-containing culture media was first removed from each 
well and disposed in bleach. Next, 400 ul of Trizol was added to the adherent cells in 
each well, allowed to sit at room temperature for 3-5 minutes, after which the lysate was 
transferred to 1.5 ml microcentrifuge tubes. Subsequent RNA isolation steps follow 
(Munger et al. 2009). Total RNA was quantified on a NanoDrop ND-2000, treated with 
DNaseI (Life Technologies, cat no. 18068-015), and converted to cDNA using the iScript 
cDNA synthesis kit (Bio-Rad, cat no. 170-8891) following manufacturer’s instructions. 
Gene expression was quantified by quantitative RT-PCR (qRT-PCR) on a 
StepOnePlus Real-time PCR System (Life Technologies). For qRT-PCR, each analysis 
was performed in technical triplicate in a total volume of 20 ul reaction mix containing 2 
ul cDNA template, 4 ul 1 uM gene-specific forward and reverse primers, 10 ul 2x 
Quantace SensiMix SYBR (Bioline, cat no. QT615-02), and 4 ul RNase-free water. The list 
of qRT-PCR primers can be found in Table S3; most have been previously published 
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(Munger et al. 2009; Jameson et al. 2012a). All primer sets were tested for efficiency and 
found to work optimally with the ΔCt method (Simon 2003). Within a sample, target 
gene Ct thresholds value were determined and normalized to Gapdh. Differences 
between target gene shRNA and non-targeting control shRNA samples were compared 
using the ΔΔCt method as described previously (Simon 2003). Significance of expression 
differences between samples was assessed using a t-test. 
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2.3 Identifying active enhancers in XY supporting cells 
2.3.1 Collecting cells 
Transgenic Sox9-ECFP mice (Kim et al. 2007) and Sox9-ECFP; Sry-EGFP mice 
were maintained on a C57Bl/6 background. To isolate pre-Sertoli cells, homozygous 
males of both genotypes were bred to CD-1 (Charles River) females in timed matings to 
generate E15.5 or E13.5 embryos. Noon of the day a vaginal plug is observed is defined 
as E0.5. Embryos were dissected and testes removed from the adjacent mesonephros. 
Testes from one or more litters were pooled together, incubated in 500 µl of 0.25% 
Trypsin-EDTA (Gibco) plus 0.25% Collagenase at 37oC of 8-10 minutes. The Trypsin-
EDTA was removed and the tissue rinsed with 1X PBS with 3% BSA, and then 
dissociated in 500 µl 1X PBS with 3% BSA. Dissociated cells were passed through a cell 
strainer (BD Falcon) to ensure a single cell suspension. Cells were sorted as described 
previously (Jameson et al. 2012b). For DNase-seq, sorted cells were pelleted, and then 
resuspended in 250 µl of Recovery-Cell Culture Freezing Media (Gibco) and slowly 
frozen to -80oC. For ChIP-seq, pelleted cells were resuspended in 360 µl of PBS and 
cross-linked with 10 µl of 37% formaldehyde at room temperature for 10 minutes. Cross-
linking was stopped by addition of 46.3 µl of 1M glycine for 5 minutes at room 
temperature. Cells were then pelleted, supernatant removed and stored at -80oC. 
Mouse tissues (kidney, liver, heart and brain) were collected from adult C57Bl/6 
mice, flash frozen and then pulverized before use. The mouse fibroblast cell line was 
derived from adult C57Bl/6 mice (Jackson Labs). ESCs, also of the C57Bl/6 strain, were 
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kindly provided by Ute Hochgeschwender (Duke University) and were grown on 
gelatinized plates in the absence of a feeder layer or matrigel. To harvest ESCs, plates 
were washed with 1X PBS and treated with 0.25% Trypsin-EDTA for 7-10 minutes at 
37oC. An equal volume of medium (containing 10% FBS) was then added to the plates to 
stop trypsinization. Cells were collected and pipetted up/down to get single cell 
suspension and were centrifuged at ~1.2 krpm for 10 minutes. All medium was removed 
from cell pellet. 
 
2.3.2 ChIP-qPCR and ChIP-seq 
30 µl of dynabeads Protein A (Life 10002D) were washed twice with 500 µl ChIP 
Dilution Buffer (CDB) (1 % Triton X-100 (Sigma T8787), 2mM EDTA, 150mM NaCl, 
20mM Tris (pH 8)) and resuspended in 30 µl of CDB. Tubes were split equally and 470 
µl of CDB with 1x Proteinase inhibitor cocktail (PIC) (Sigma P8340) and 1x 
Phenylmethanesulfonyl fluoride (PMSF) (Sigma 93482) was added to each tube. 
Antibodies (H3K4me1 (4 µl) – Active Motif 39298, H3K27ac (2.5 µg) - abcam ab4729) 
were added to each tube. Tubes were put into an end-over-end rotator for >4 hours at 
4oC.  
1M cells were pooled from multiple sorts (for gonad cells) or from cultures 
(C2C12) and washed twice in 500 µl of PBS with 1x PIC and 1x PMSF. Cells were 
resuspended in 500 µl of lysis buffer (50mM Tris-HCL, 10mM EDTA, 1% SDS)  with 1x 
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PIC and 1x PMSF and sonicated with Branson 450 Sonicator at output power of 3, duty 
cycle of 30% for 16 cycles of 30 seconds with 1 minute rest time between sonications.  
Lysate was spun down at 4oC for 10 minutes at 100krpm. 440 µl of lysate was put 
into a new tube, with 200 µl added to each pre-incubated dynabeads and antibody 
(K4me1 and K27ac) tube and 40 µl in a tube for input. We added 700 µl of CDB with 1x 
PIC and 1x PMSF to IP tubes and incubated in an end-over-end rotator at 4oC overnight. 
160 µl of CDB and 8 µl of 5M NaCl were added to the input and the tube was placed at 
65oC.  
The following day, washes were performed on the IP tubes as follows: Once with 
Wash Buffer 1 (50mM Tris HCl, 1mM EDTA, 150 mM NaCl, 0.1% SDS, 0.1% Triton X-
100, 0.1% Sodium deoxycholate), twice with Wash Buffer 2 (50mM Tris HCl, 1mM 
EDTA, 500 mM NaCl, 0.1% SDS, 0.1% Triton X-100, 0.1% Sodium deoxycholate), once 
with Wash Buffer 3 (10mM Tris HCl, 1mM EDTA, 1% NP-40, 1% Sodium deoxycholate, 
250mM LiCl), twice with Wash Buffer 4 (50mM Tris HCl, 1mM EDTA, 500 mM LiCl, 1% 
NP-40, 0.7% Sodium deoxycholate), twice with TE buffer [8.0]. All washes were done 
with 1mL at 4oC for 5 minutes. 1x PIC and PMSF were added to all buffers. DNA-protein 
complexes were eluted twice from the beads with 100 µl elution buffer (100mM sodium 
bicarbonate, 1% SDS, 8mM NaOH). 8 µl of NaCl was added to the eluates and tubes 
were placed on 65oC overnight. Solutions for wash buffers were mainly gleaned from 
the protocols posted on the Epigenomics Roadmap website.   
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All tubes were removed from 65oC heat block and left to cool to room 
temperature. 1 µl of RNase-cocktail (Life AM2286) was added to each tube. Tubes were 
incubated for 30 minutes at 37oC. Following this, 4 µl of 0.5M EDTA, 8 µl of 1M Tris and 
1 µl of Proteinase K was added. Tubes were incubated at 45oC for 60 minutes. DNA was 
purified using QIAgen PCR purification columns (28104).  
For ChIP-qPCR, qPCR was performed as before. The percent input method was 
used to calculate enrichment (Haring et al. 2007). For library preparation for sequencing, 
DNA was concentrated using a vacuum centrifuge to ~10 µl. 10 µl of IP DNA and 1ng of 
input DNA was used in the library preparation. The Rubicon ThruPLEX FD kit was 
used for library preparation according to the manufacturer’s protocol. Size selection of 
smaller size amplified DNA was done with SPRI beads (Agencourt AMPure XP A63880) 
at 0.6x concentration.   
ChIP-seq analysis was performed with SICER (Zang et al. 2009). Enrichment was 
called for the histone modifications using the input track as the control. The species 
variable was set to mm9, redundancy threshold to 2, window size to 200, fragment size 
to 150, effective genome fraction to 0.7, gap size to 600 and FDR to 0.01.  
 
2.3.3 Overlap analysis with different regions 
Various types of genomic locations were put into bed files including TSS, genic, 
intronic and exonic. These regions were extracted from UCSC genome browser. Bed files 
for date from other cell types were used. Overlap was calculated by using bedtools 
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(Quinlan and Hall 2010) with an overlap of 1bp being sufficient. Similar analysis was 
done to identify overlap between DHSs and K27ac peaks.  
 
2.3.4 Assigning DHSs to different genes 
DHSs were assigned to genes based on their location in an approach similar to 
the GREAT algorithm (McLean et al. 2010). The domain for each gene was extended 
1Mb from the TSS and Transcription End Site (TES) until they encountered the TSS -5kb 
of another gene. Based on gene categories from (Jameson et al. 2012b), boxplots of the 
DHSs belonging to these regions were constructed (Figure 34). A two-sided Mann-
Whitney test was used to compare the distributions of number of DHSs. 
 
2.3.5 Transient transgenics, Immunocytochemistry and Imaging 
A putative regulatory region (UCSC mm9 coordinates chr2:104914099-
104915125) upstream of Wt1 was amplified by PCR and cloned into the NotI site of the 
Hsp68 –LacZ reporter vector (obtained from Addgene; Plasmid #33351). Cloning was 
carried out using the In-Fusion HD (Clonetech) reagent. To prepare DNA for zygote 
injection, 50 µg of the TgWt1 plasmid was linearized with NotI-HF and HindIII and gel 
purified by electroelution. DNA was phenol-choloform extracted, ethanol precipitated 
and resuspended in EmbryoMax Injection Buffer (Millipore, MR-095-10F). The DNA 
was further purified on a DNA-cleanup column (Qiagen) and eluted again in 
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EmbryoMax Injection Buffer. Pronuclear injections into B6SJLF1/J zygotes were 
performed by the Duke Transgenic Core Facility to generate transient transgenics. 
Embryos were dissected at E13.5 and the embryonic tail was removed for 
genotyping to detect the LacZ gene.  Gonads were carefully dissected from embryos and 
fixed in 4% paraformaldehyde for several hours or overnight at 4oC. The remaining 
embryo bodies were fixed in 4% paraformaldehyde for 8 minutes, washed in X-gal wash 
buffer (2mM MgCl2, 0.2% NP-40 in 1X PBS) and then incubated overnight at 37oC in X-
gal staining solution (5mM potassium ferrocyanide, 5mM potassium ferricyanide, 
1mg/ml X-gal in X-gal wash buffer).  
For immunostaining, fixed gonads were washed three times in 1X PBS and 
incubated in blocking solution (10% FBS, 3% BSA and 0.1% Triton-X-100 in 1X PBS) for 1 
hr at room temperature. Blocking solution was replaced with primary antibodies diluted 
in blocking solution and incubated overnight at 4oC. The next morning, samples were 
washed three times in washing solution (1% FBS, 3% BSA and 0.1% Triton-X-100 in 1X 
PBS) followed by one hour incubation with blocking solution. Samples were then 
incubated with secondary antibodies, diluted in blocking solution, overnight at 4oC. 
Following three washes, samples were then mounted in DABCO (2.5% 1,4, diazagicyclo 
octane, 90% glycerol in 1X PBS). Images were taken on a Leica SP2 confocal microscope.  
Primary and secondary antibodies were used at the following dilutions: rat-anti-
CDH1, 1:250 (Zymed, 13-1900);  rabbit-anti- -galactosidase, 1:10,000 (MP Biomedicals, 
55976); goat-anti-MIS/AMH, 1:250 (Santa Cruz, sc-6886); Alexa Fluor 488-anti-rat, 1:500 
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(Molecular Probes, A21208); Cy3-anti-rabbit, 1:500 (Jackson ImmunoResearch 
Laboratories, 711-165-15); Alexa Fluor 647-anti-goat, 1:500 (Molecular Probes, A21447).  
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3. Predicting cell-type specific expression from regions 
of open chromatin 
3.1 Summary 
Complex patterns of cell-type specific gene expression are thought to be achieved 
by combinatorial binding of transcription factors (TFs) to sequence elements in 
regulatory regions. Predicting cell-type specific expression in mammals has been 
hindered by the oftentimes unknown location of distal regulatory regions. To alleviate 
this bottleneck, we used DNase-seq data from 19 diverse cell types to identify proximal 
and distal regulatory elements at genome-wide scale. Matched expression data allowed 
us to separate genes into classes of cell-type specific up-regulated, down-regulated, and 
constitutively expressed genes. CG dinucleotide content and DNA accessibility in the 
promoters of these three classes displayed substantial differences, highlighting the 
importance of including these aspects into modeling gene expression. We associated 
DNaseI Hypersensitive Sites (DHS) with genes, and trained classifiers for different 
expression patterns. TF sequence motif matches in DHS provided a strong performance 
improvement in predicting gene expression over the typical baseline approach of using 
proximal promoter sequences. In particular, we achieved competitive performance 
when discriminating up-regulated genes from different cell types or genes up- and 
down-regulated under the same conditions. We identified previously known and new 
candidate cell-type specific regulators. The models generated testable predictions of 
activating or repressive functions of regulators. DNaseI footprints for these regulators 
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were indicative of their direct binding to DNA. In summary, we successfully used 
information of open chromatin obtained by a single assay, DNase-seq, to address the 
problem of predicting cell-type specific gene expression in mammalian organisms 
directly from regulatory sequence. 
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3.2 Introduction 
Genome-wide techniques, such as chromatin immunoprecipitation followed by 
microarrays or sequencing (ChIP-chip and ChIP-seq), have been instrumental in 
identifying precise TFBS which can then be used to predict gene expression. For 
example, ChIP data for 12 key TFs in embryonic stem (ES) cells was used to predict both 
absolute and relative expression values with high accuracy (Chen et al. 2008; Ouyang et 
al. 2009). While impressive, it is important to note the difficulty in procuring this kind of 
data across a wide variety of cell types. First, in order to conduct ChIP one needs a high 
quality antibody or tagged protein, which is not always available for the TF(s) of 
interest. Second, TFs have to be assayed individually, which requires many independent 
ChIP experiments to identify combinatorial patterns of TF binding. Finally, for this 
method to succeed, one must have a good understanding of the cell type in question to 
know which TFs to analyze. As a result, for most cell types there is not enough 
information available on the binding profiles of TFs to predict cell-type specific gene 
expression. Therefore, developing predictive models of gene expression without relying 
on ChIP would facilitate our understanding of transcriptional regulation. 
A more widely applicable alternative to ChIP is to use known cognate binding 
preferences for TFs determined from assays such as SELEX, ChIP-seq, ChIP-chip and 
Protein Binding Microarrays (PBMs) (Stormo and Zhao 2010) to find TFBSs in putative 
regulatory regions. However, without knowing the location of distal regulatory regions, 
most studies using this method focus exclusively on TFBS identified in proximal 
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promoter sequences (Das et al. 2006; Ramsey et al. 2008; Sinha et al. 2008; Suzuki et al. 
2009). Using these sequence features has revealed, for example, a crucial CG content 
difference between cell-type specific and constitutively expressed genes in mammalian 
organisms (Yamashita et al. 2005; Carninci et al. 2006). However, these approaches have 
frequently struggled to distinguish between more specific patterns, such as predicting 
cell-type specific expression across many cell types. A comprehensive understanding of 
cell-type specific expression will require identification of both proximal promoter and 
distal regulatory elements.  While comparative genomics has been successfully used to 
pinpoint functionally relevant regions, recent reports have stressed the complexity of 
evolution in functional non-coding regions and the resulting frequent lack of sequence 
conservation (Ludwig et al. 2005; Odom et al. 2007; Blow et al. 2010). 
For over three decades, mapping DNaseI hypersensitive sites (DHSs) has been 
employed to identify the location of many types of active gene regulatory elements (Wu 
and Gilbert 1981). DNaseI is an enzyme that preferentially digests DNA in regions of 
low nucleosome occupancy, i.e. regions of open or accessible chromatin. DHSs have 
been found to be well correlated with genomic features such as transcription start sites 
(TSSs), distal enhancers, insulators, transcription factor binding sites, and active histone 
marks (Heintzman et al. 2007; Boyle et al. 2008a; Heintzman et al. 2009). A recent study 
profiling open chromatin in 7 cell types in a genome-wide fashion using DNase-seq 
highlighted that open chromatin regions are similar across functionally related cell 
types, that cell-type specific regions are distal to TSSs, and identified groups of DHSs 
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that show coordinated nucleosome depletion (Song et al. 2011). Other studies have 
indicated that DNase-seq data can be used to identify TFBSs at single-nucleotide 
resolution (Hesselberth et al. 2009; Boyle et al. 2011; Pique-Regi et al. 2011).  
In this study, we use DNase-seq data across 19 diverse human cell lines to define 
proximal and distal regulatory regions, and to quantify the contribution of sequence 
features in DHSs to specify different patterns of cell-type specific gene expression. Using 
expression data from the same 19 cell types, we define classes of up-regulated, down-
regulated and constitutively expressed genes, which show distinct patterns of chromatin 
accessibility. We then build predictive models specifically for these different expression 
classes, by using the binding site matches that map within DHSs. Crucially, these 
models dramatically improve on baseline models of proximal promoter regions, and 
specifically control for the impact of promoter CG content on classifier performance.  
Our results demonstrate the crucial role for sequence features in open chromatin 
regions for determining expression patterns, and its usefulness for building predictive 
regulatory models. We confirm many known regulatory interactions and identify novel 
putative positive and negative regulators of gene expression. We also reveal the 
presence of DNase footprints for specific TFs that are identified as predictive in our 
model indicating direct binding to DNA. Our work provides a general and easily 
extensible framework to address questions related to gene regulation in vertebrates.   
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3.3 Results 
3.3.1 DHSs have different properties depending on their genomic 
location 
As part of the ENCODE project, DNase-seq has been performed in several 
human cell lines representing a wide variety of tissue types. Aligned reads were used to 
define DNaseI hypersensitive regions (DHS; see Methods for details). Of these, we 
selected 19 cell lines to represent a broad and largely unrelated variety of cell types. 
These include DNase-seq data from a recent study across 7 cell lines (Song et al. 2011). In 
each of the 19 cell lines we used, DHS regions cover ~2% of the genome (Table 1).  This 
indicates that a large proportion of cis-elements likely to be involved in establishing the 
expression patterns in each cell line only comprise a small fraction of the genome. Such 
regions may encode specific activation patterns of genes, but also include insulators that 
can define target relationships. A hallmark of insulators is the presence of binding sites 
for the CCCTC binding factor (CTCF). Across the 9 cell types for which CTCF ChIP-seq 
data is available, ~28% of DHS overlapped CTCF bound sites, in agreement with recent 
work (Song et al. 2011). 
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Table 1: Number of DHS per cell line and the total number of bases covered 
by the DHS peaks 
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Based on their genomic location, DHS were divided into exclusive classes as 
follows. We first identified a set of TSS DHS as those that overlapped the transcription 
start sites (TSS) of genes based on Refseq hg19 annotation (Figure 3A). Other DHS were 
designated as Gene Body DHS if they overlapped exons or introns, and as Intergenic 
DHS if they did not overlap any genes. The median size of all DHS was approximately 
300bp, with the TSS DHS set as outlier with a median size of ~ 1kb (Figure 3B). The 
larger size of TSS DHS may reflect the presence of larger and more stable complexes 
such as the Pre-Initiation Complex (PIC) near the TSS of genes.  
The normalized CG dinucleotide content of Gene Body and Intergenic DHS 
showed a median of 0.28 and 0.26, respectively (Figure 3C). For TSS DHS, the 
normalized CG content showed a unimodal distribution with its mode at ~0.8, with a 
heavy tail of several DHS with CG content below 0.6.  
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Figure 3: Properties of DHS based on genomic location 
  
(A)  DHS that are intergenic and those that are overlapping the TSS and gene 
body were classified as Intergenic, TSS and gene body DHS, respectively (Chr1: 
201,566,484 – 201,683,121).  (B) Sizes of different DHS for the Chorion cell line. Data from 
only one cell line was used to avoid multiple counting of ubiquitous DHS. Other cell 
lines show similar trends. Outliers are not plotted. (C) Violin plot showing normalized 
CG content for different DHS in the Chorion cell line. The subset of DHSs with 
normalized CG content of zero are comparatively small (median of 128 bp). 
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3.3.2 A large proportion of TSSs are found in regions of accessible 
chromatin 
To understand how regions of open chromatin vary between cell types, we 
inspected the degree to which DHSs were shared in the 19 cell types. DHSs were 
classified as being specific to a cell line if it was only present in a single cell type or 
overlapped less than 50% of its length with a DHS from any of the other 18 cell types 
(Figure 4A). Across all DHSs ~14% were specific to a single cell line (Figure 4B). 
Intergenic DHS showed the highest percentage of being cell-type specific (~17%). 
Conversely, TSS DHS were largely not cell-type specific with less than 1% being open 
specifically in a single cell type. Despite the broad panel of cell lines that vary in 
expression, the chromatin state at the TSS of these genes was open and largely invariant 
across multiple cell lines. This is in agreement with a recent study analyzing a subset of 
the cell types used here (Song et al. 2011). 
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Figure 4: Cell-type specificity of hypersensitive regions. 
(A) Example (Chr1: 201,890,462 – 201,938,914) showing cell-type specific DHS 
across two cell lines. Note that we called a DHS cell-type specific if it did not overlap 
another DHS by more than half in any of the 18 other cell line.  (B) Bar graph showing 
the proportions of cell-type specific DHS across different genomic locations averaged 
across all cell lines. (C) TSSs were divided by the number of cell lines they were in a 
region of open chromatin. For each set of TSS, normalized CG content in the promoter 
regions (-900,100) of the TSS are shown.  
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We determined the normalized CG content in the proximal promoter region of 
the gene, defining the proximal promoter as -900 to +100 bp around the TSS. If a gene 
had multiple TSSs, the average of the normalized CG content from each TSS was used. 
There was a steady positive trend in the number of cell lines in which a DHS overlapped 
a TSS and the CG content around the TSS (Figure 4C). Previous studies have reported 
that gene expression can be predicted from the CG content in the proximal promoter 
region (Yamashita et al. 2005; Carninci et al. 2006; Zhu et al. 2008). Our result indicates 
that higher levels of CG dinucleotide content, and thus more frequent presence of CpG 
islands, are positively correlated with, and could be functioning to preserve, an open 
chromatin state surrounding the TSS. There were fewer genes with a TSS open in only 
one cell type (976 genes) and many with an open TSS across all 19 cell types (8393). 
 
3.3.3 Cell-type specific expressed genes show differing patterns of 
accessible chromatin at their TSS 
Gene expression data for the 19 cell lines were generated using Affymetrix exon 
arrays. Expression values for each gene were transformed to z-scores across all the cell 
lines. Genes with large positive or negative z-score values thus showed a larger 
deviation from the mean expression across cell types. The z-score transformed 
expression values were used to select subsets of genes with specific expression patterns 
(Figure 5A-C). Up-regulated genes, exemplified by GCM1 (Figure 5A) had a particularly 
high expression in one cell line, but expression close to the mean in the other cell lines. 
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To identify genes exhibiting this type of expression pattern, we sorted the z-score 
expression for the genes in each cell line. The top 200 genes in this sorted list were 
classified as being up-regulated in that cell type (UR genes). Down-regulated genes 
exhibit low expression levels in one cell type, but are otherwise constitutively expressed 
in other cell lines (Figure 5B) (Thorrez et al. 2011). We classified the last 200 genes in the 
sorted z-score expression list as being the cell-type specific down-regulated genes (DR 
genes). Constitutively expressed genes (Figure 5C) were identified by filtering all genes 
that were not in UR and DR gene sets in any cell line and had absolute expression z-
score values < 1.7 in all cell lines. Using this cutoff, 168 genes displayed a pattern of 
constant expression levels across all cell lines.  
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Figure 5: Cell-type specific gene expression and definition of gene classes 
(A, B and C) Representative examples of different patterns of gene expression. 
Note that z-score values are calculated from expression across all 19 cell lines. (A) A 
gene where the expression is specifically up-regulated in the first cell line (UR gene).  (B) 
A gene that is specifically down-regulated in the first cell line (DR gene). (C) A gene that 
has low variability in expression (Constitutively expressed gene). (D) Median expression 
z-scores for the genes in each set in each cell line. (E) Normalized CG content from the 
promoter regions of genes. (F) The fraction of TSS in each gene set that were in a region 
of open chromatin.  (E and F) share the same color map.  
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To address how up-regulated genes are expressed in one particular cell type, we 
grouped UR genes from all other cell types and denoted this group as UR-Other genes 
(Figure 5A). We imposed the additional constraint that such genes would show an 
expression z-score < 0 in the cell type of consideration, i.e., had expression below its 
mean expression. As an example, GCM1 (Figure 5A) was highly expressed in the first 
cell type and in none of the others shown. It was therefore grouped into the UR class for 
the first cell type, and into the UR-Other class in each of the other cell types. Similarly, 
genes denoted as DR-Other had to be classified as down-regulated in another cell line 
and had an expression z-score > 0 in the cell type of consideration (Figure 5B). In this 
way, we defined different classes of transcriptionally active (UR, DR-other, and 
Constitutive) and transcriptionally inactive genes (UR-other, DR) from the point of view 
of each cell line in comparison to other cell lines. 
By definition, UR and DR genes displayed the highest and lowest z-score gene 
expression, respectively (Figure 5D). UR genes were consequently enriched in functions 
related to the tissue type of origin (Table 2). DR-other and constitutive genes showed 
similar expression values and had higher expression values than genes in the UR-other 
class. To understand whether these different classes had different properties in sequence 
composition and chromatin state, we first inspected normalized CG content in the 
proximal promoter region (Figure 5E). UR and UR-Other genes had the lowest average 
CG content compared to the other classes of genes. Constitutively expressed genes 
displayed a particularly high CG content in their proximal promoter regions, as 
 64 
 
previously reported (Yamashita et al. 2005; Carninci et al. 2006; Zhu et al. 2008); 
however, this observation clearly extended to the DR and DR-Other gene classes, which 
had a CG content slightly lower than constitutively expressed genes.  
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Table 2: GO analysis for UR genes in each cell line.  
 
The UP_Tissue entries from DAVID were used to identify the similarity of 
expression to known tissue types. 
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Constitutively expressed and DR-Other genes had the highest proportion of their 
TSS in regions of accessible chromatin (Figure 5F).  DR genes displayed slightly lower 
chromatin accessibility compared to DR-Other, indicating that repression of DR genes 
largely occurs while maintaining chromatin accessibility at the TSS. UR genes also 
showed a high proportion of genes containing an accessible TSS, at similar levels to DR 
and DR-Other. In stark contrast, UR-Other genes had the lowest fraction of TSSs that 
overlapped a DHS. These results indicate that even though UR-other and DR genes are 
both transcriptionally inactive in a cell type of consideration compared to other cell 
types, they are likely to be regulated via different chromatin remodeling mechanisms. 
Specifically, genes that are up-regulated in a small number of cell types likely maintain a 
closed chromatin conformation until cellular processes require up-regulation. In 
contrast, down-regulated genes may be viewed as constitutively expressed genes that 
are repressed in a single cell type. UR genes had intergenic and gene body DHS 
associated with them (Figure 6), in agreement with previous results indicating that cell-
type specific expression is mediated by distal cis-regulatory regions (Song et al. 2011). 
Overall, these results indicate that different classes of transcriptionally active and 
inactive genes have different CG content and chromatin accessibility at their TSS. 
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Figure 6: The fraction of genes in each gene set that had Intergenic DHSs and 
Gene Body DHS 
 68 
 
3.3.4 Classifying tissue-specific expression from sequence features 
in open chromatin 
 To predict gene expression patterns from sequence, approaches have frequently 
used features contained within fixed-size proximal promoter sequences. We used DHS 
data from a large number of cell types to determine whether using both proximal and 
distal regulatory regions with open chromatin would improve predictive models for 
cell-type specific expression patterns.  Position Weight Matrices (PWMs) for TFs in 
vertebrates were compiled from Transfac, JASPAR and UniProbe databases (Matys et al. 
2006; Bryne et al. 2008; Newburger and Bulyk 2009). For each DHS, 789 PWMs were 
used to calculate TFBS scores that accounted for local dinucleotide composition. The 
maximum sliding window score for each PWM was used as the TFBS score for that DHS 
(Figure 7A). To associate DHS with specific genes that they are likely to regulate, we 
applied a simple approach of associating each DHS with the closest TSS (closest gene 
DHS). For each TF, we then chose the maximum TFBS score across all DHS associated 
with a gene (Figure 7B). As an alternative approach, we split DHS into distal sites (a set 
including both Gene-Body and Intergenic DHS) and TSS DHS sites and used the 
maximum TFBS in each set as individual features (split DHS). This doubled the number 
of features and allowed us to identify different characteristics of TSS-overlapping vs. 
distal DHS. To compare our models to previous approaches, we also used TFBS features 
calculated in proximal promoters, defined here as -900 to +100 nucleotides surrounding 
the TSS (Landolin et al. 2010). 
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Figure 7: Transcription factor binding site as features 
(A) DHS and promoter sequences are scanned with PWMs. TFBS scores are log-
likelihood ratios of PWM over the background model. A sliding window is used to 
identify the score for each DHS or Promoter. (B) Example to show association of DHS 
with genes. Numbers in the brackets are example TFBS scores for the DHS for a specific 
DHS. Two methods of association were used. In closest gene DHS, DHS 1- 4 from the 
GM12878 cell line are associated with the gene MAFB. For the TF in consideration, the 
maximum of all TFBS scores is 2.3. In Split DHS, we separated DHS overlapping the TSS 
and other DHS. This resulted in two features for each gene for each TF. 
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We used the TFBS scores as features for sparse logistic regression classifiers to 
discriminate between different gene classes. These classifiers balance the use of many 
available features against model complexity, effectively selecting a small subset of 
informative features which are used in the classification. We trained cell-type specific 
classifiers on the task to discern whether a gene belonged to a specific expression pattern 
(e.g., UR vs. UR-Other, UR vs. DR, UR vs. constitutive, etc.). The area under the Receiver 
Operating Characteristic curve (AuROC) metric was used to evaluate the performance 
of a model, where a value of 0.5 indicates random assignments and 1.0 indicates perfect 
classification. To not bias results due to different amounts of training data, the positive 
sets of up- and down-regulated genes were all of the same size. 
The performance of the classifier using only proximal promoter information is 
close to that of a random classifier, across all tasks. All the classifiers using DHS 
sequences display strong improvements in performance over this baseline in 
discriminating genes that are up-regulated in different cell types (UR vs. UR-Other, 
Figure 8A), with a greater improvement in performance coming from the Split DHS 
approach with separate features for the TSS and Distal DHSs (median AuROC ~0.73). 
Similar results were obtained when training classifiers to distinguish between 
specifically up- and down-regulated genes from the same cell types (UR vs. DR, Figure 
8B), and to distinguish up-regulated from constitutively expressed genes (UR vs. Const., 
Figure 8C). Discriminating down-regulated  genes from different cell types (DR vs. DR-
Other), and down-regulated from constitutively expressed genes (DR vs. Const.), 
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resulted in lower accuracies but still showed the trend of better performance with DHS 
compared to proximal promoter sequence (Figure 9). All results clearly indicate that 
strong performance improvement is achieved by scanning for TFBS matches in open 
chromatin regions. 
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Figure 8: Classifier performance for various classification tasks with UR genes 
(A, B, C) Performance of the classifier using all PWMs. Each figure compares the 
performance of 2 methods of associating DHSs to genes (Closest Gene DHS and Split 
DHS) with the proximal promoter. The solid black lines across the dots indicate the 
median. Across all figures, the promoter sequence classifier does not perform as well as 
the performance achieved by using closest gene DHS and Split DHS and is significant at 
the 0.05 level (paired t-test). (D, E, F) Impact of normalized CG dinucleotide content on 
classifier performance. Results using the Split DHS and Promoter sequence are shown. 
Without CG data is same as in A-C. All figures show average results from 5 iterations of 
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4-fold cross-validation. The dotted line indicates an AuROC of 0.5 which is the 
performance of a random classifier.  
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Figure 9: Classifier performance for various classification tasks with DR genes 
(A, B) Performance of the classifier using all PWMs. Each figure compares the 
performance of 2 methods of associating DHSs to genes (Closest Gene DHS and Split 
DHS) with the proximal promoter. Across all figures, the promoter sequence classifier 
does not work as well as the performance achieved by using closest gene DHS and Split 
DHS and is significant at the 0.05 level (t-test). The black lines across the dots indicate 
the median. All figures show results from 5 iterations of 4-fold cross-validation. The 
dotted line indicates an AuROC of 0.5 which is the performance of a random classifier. 
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3.3.5 Evaluating the influence of CG dinucleotide content 
CG dinucleotide content in the proximal promoter sequence of genes is a 
common sequence feature that is directly or implicitly used to distinguish various 
classes of genes.  Adding CG dinucleotide content as an additional feature led to a 
variable impact on classifier performance depending on the classification being 
considered (Figure 8D-F). Specifically, when using open chromatin information, adding 
CG content did not substantially improve the performance of classifying UR genes from 
UR-Other genes (Figure 8D). In the case of the Split DHS, only 6 of the cell lines had a 
significant coefficient for the CG dinucleotide coefficient (mean across all cell lines = -
0.66, std. dev. = 1.40; coefficient was set to 0 when not significant). Due to the means 
being close to zero and the standard deviations being large, the effect of using CG 
content to discriminate between UR and UR-Other genes was largely negligible. Only 
for few cell types, such as hepatocytes, we observed a negative regression coefficients of 
significant magnitude (-5.11 for Split DHS and -3.31 for Promoters). This is in agreement 
with previous results showing that liver specific genes have promoters with lower CpG 
content (Smith et al. 2005). 
As anticipated by the trends observed in Figure 5E, UR vs. DR classification tasks 
benefitted more by the addition of CpG content. Here, this feature was deemed to be 
significant in 17 of the cell lines for the Split DHS (Figure 8E). Further, the regression 
coefficients were largely negative which indicated the higher CG content among the DR 
genes (mean = -2.88, std. dev = 1.55). As has been shown before (Yamashita et al. 2005; 
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Carninci et al. 2006; Zhu et al. 2008), we observed that high CpG content is predictive of 
constitutively expressed genes when compared to UR genes (Figure 8F). The regression 
coefficient for the feature was significant in all cases (mean = -3.25, std. dev 1.44). The 
CpG content feature had almost no impact in classifying DR from DR-Other genes 
(Figure 9). Finally, CpG content had a significant coefficient in classifying DR from 
Constitutively expressed genes in only 1 cell line (mean = -0.09, std. dev. = 0.39).  
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Figure 10: Impact of normalized CG dinucleotide content on classifier 
performance for discriminating DR genes. 
(A, B) Results using the Split DHS and Promoter sequence are shown. The dotted 
line indicates an AuROC of 0.5 which is the performance of a random classifier. CG 
content is shown to help for the proximal promoter where other factors are not 
informative. 
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Adding CG content to the baseline proximal promoter models reconciled the 
apparent discrepancies between previous studies and results reported in Figure 8A-C, as 
all classification tasks were improved upon for the proximal promoter. However, the 
DHS models with CG content outperformed baseline proximal promoter models with 
the inclusion of CG content (paired t-test < 0.05). In fact in all cases except UR vs. 
constitutive genes, DHS models even without CG content perform significantly better 
than both proximal promoter models (paired t-test < 0.05). Note that while adding CG 
content provided enormous performance gains for certain classification tasks (UR genes 
vs. Constitutive genes) this could be considered misleading. If TFBS scores are not 
explicitly normalized for local nucleotide composition, as we have done here, decent 
performance results can be achieved based solely on the different CG content observed 
for down-regulated and constitutively expressed genes compared to up-regulated genes. 
CG content is predictive in the case of classifying constitutive and DR genes from UR 
genes, but is not very useful in differentiating between genes that are up- or down-
regulated in different cell types.  It is notable that the categories that are less aided by 
CG content are exactly those where our classifiers displayed the most predictive value. 
 
3.3.6 Identifying candidate regulators 
In addition to classifying genes belonging to different groups, we inspected the 
classifiers to identify motifs that were most informative in the classification task, i.e., 
those PWMs that had large regression coefficients (Table 3). This identified several TFs 
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with known impact on transcriptional output in the cell line of interest. For example, 
YY1, SPI1 and IRF8 are crucial in the specification of B-cells (GM12878 cell line) (Lu et al. 
2003; Liu et al. 2007; Sokalski et al. 2011). We also identified the REST motif as a positive 
regulator of UR genes in medulloblastoma cell line that is of neural origin (Table 3). 
REST specifically down-regulates neuron-specific genes in many non-neuronal cell lines, 
and its expression is suppressed in neurons (Schoenherr and Anderson 1995). As a 
result, the model identified the cis-elements that are present in the DHS associated with 
neuron specific genes as the factor that separates these genes from the genes up-
regulated elsewhere. This example illustrates that the inactivation of a repressor can also 
explain up-regulation of genes.  Other well characterized factors included ETS1 in 
HUVEC cells and HNF4A for HepG2 cells (Cereghini 1996; Oda et al. 1999; Yordy et al. 
2005). 
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Table 3: Results for each cell line using Split DHS from All TFs for the UR – 
UR Other and UR – DR classification task.  
 
TFs with positive and negative coefficients are shown for both sets of TFs used. 
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The feature set described thus far was comprehensive in that it used available 
PWM information from multiple sources, independent of the expression levels of 
transcription factors or the potential redundancy of features. To assess how much cell-
type specific regulation can be explained by the cell-type specific expression of 
transcription factors themselves, we selected the top 10 TFs with highest absolute z-
scores from each cell line and had PWMs that were not similar to each other (Table 4).  
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Table 4: Top 10 non-redundant TFs with highest absolute expression z-score in 
each cell line.  
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Using sparse logistic regression classifiers trained on these small sets of 
variables, we observed similar predictive trends, which indicated that a subset of cell-
type specific TFs were predictive of tissue-specific expression (Figure 11). Using only 
promoter CG content or the status of the chromatin at the TSS as features for a baseline 
comparison shows that motifs in DHS regions significantly contribute to the 
performance improvement across all comparisons. In addition, we used genomic 
regions identified as conserved in the 46-way placental mammal phastCons track from 
the UCSC genome browser. We note that using conserved sequences and particularly 
conserved non-coding regions improved performance compared to the promoter. 
However, the AuROC was still highest when DHS sequences were used indicating the 
presence of motifs in weakly conserved DHS regions contribute to the performance 
improvement. Finally, to assess the potential influence of insulators, we excluded DHS 
that overlapped CTCF binding sites for classifiers trained specifically for the 9 cell types 
for which genome-wide CTCF ChIP data was available (Figure 12). While this did not 
impact classification of UR genes, it reduced the accuracy of identifying DR genes, 
demonstrating that regions containing insulator sites are likely to contain regulatory 
information for the repression of genes. 
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Figure 11: Performance of classifier using top 10 non-redundant highest 
absolute z-score 
Each figure compares the performance of Split DHS with the proximal promoter. 
Across all figures, the promoter sequence classifier does not work as well as the 
performance achieved by using Split DHS. The black line across the dots indicates the 
median. In addition, the impact of CG content, and knowing the whether the promoter 
is open is shown. All figures show results from 5 iterations of 4-fold cross-validation. 
The dotted line indicates an AuROC of 0.5 which is the performance of a random 
classifier. 
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Figure 12: Performance of classifier using top 10 non-redundant highest 
absolute z-score using DHS with or without CTCF 
Each figure compares the performance of 2 methods of associating DHSs to 
genes using Closest Gene DHS and the inclusion and exclusion of DHS with CTCF 
ChIP-seq peaks and with the proximal promoter. Note that only 9 cell lines had CTCF 
ChIP-seq data. All figures show results from 5 iterations of 4-fold cross-validation. The 
dotted line indicates an AuROC of 0.5 which is the performance of a random classifier. 
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Knowing both the regression coefficient in our model and the expression level of 
a potential regulator provided clues as to whether the TF in question is an activator or a 
repressor in the cell line, as highlighted for REST in medulloblastoma cells (Table 5). As 
another example, NR2F2 was identified as a positive predictor of up-regulated genes for 
embryonic stem cells. However, NR2F2 is a known negative regulator of POU5F1, a 
critical gene involved in pluripotency (Rosa and Brivanlou 2011). As expected, NR2F2 is 
down-regulated in ES cells. We also identified other known positive regulators, such as 
GATA1 in K562 cells, (Huang et al. 2005) and MYF6 in Myotubes (Fan et al. 2011). Note 
that genes that have both positive and negative coefficients have different effects when 
in TSS DHS and Distal DHS. 
 87 
 
 
Table 5: Classifier performance for each cell line using Split DHS from Top 10 
highest absolute z-score of expression and non-redundant TFs 
 
UR vs. UR-Other and UR vs. DR classification tasks are shown. TFs with positive 
and negative coefficients are shown for both tasks. Genes in bold are up-regulated and 
other genes are down-regulated in the cell line. Several of the same factors help in 
classifying UR vs. UR-Other genes and UR vs. DR genes. 
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For HNF4A in HepG2 and GATA1 in K562 cells, ChIP data is available from the 
ENCODE project. To validate the predictions made by our model, we looked for overlap 
of these ChIP sites with DHS sites associated with different sets of genes. In HepG2 cells, 
19% of all genes with an associated DHS overlapped a HNF4A binding site. Strikingly, 
64.5% of the UR genes had a DHS overlapping an HNF4A ChIP peak (p-value<1e-12, 
binomial test). Conversely, only 10.5% of DR genes had a DHS that overlapped an 
HNF4A site (p-value<1e-3). In K562 cells, we found that 6% of all genes had an 
associated DHS with a GATA1 ChIP peak. However, 31.5% (p-value<1e-12) of UR genes 
and only 3.5% (p-value<0.1) of DR genes had a DHS with a GATA ChIP peak. The ChIP 
binding data provided strong and independent evidence that our models identify 
relevant factors that regulate the transcriptional program in these cells. 
In addition, we investigated the accuracy of our predictions of TFBS locations in 
DHS. In HepG2, 5215 of the 6597 HNF4A ChIP peaks overlapped the predicted TFBS in 
DHSs. Furthermore, using TFBS scores led to a high accuracy on discriminating between 
positive and negative sets defined by ChIP peaks (AuROC of 0.79). In K562 cells, only 
315 of the 1704 GATA1 ChIP peaks overlapped the predicted TFBS in the DHS; yet, the 
AuROC still remained high at a value of 0.88. This indicated that high scoring TFBSs 
accurately predicted binding of GATA1 to these sites. We note that the low percent 
overlap may arise from non-specific or indirect binding of GATA1. 
To assess the presence of additional sequence motifs not accounted for by the 
sets of known PWMs, we used the discriminative version of MEME to perform motif 
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finding (Bailey et al. 2010), identifying motifs differentially enriched between UR and 
UR-other respectively DR genes (Table 6). While some of the identified motifs 
corroborated the importance of features from the set of top 10 TFs (FOXA2 [formerly 
HNF3B] in HepG2), others corresponded to TFs that were not in this list. These are 
candidate TFs that are not among the most differentially expressed, but still might be 
involved in the transcriptional program, potentially through other steps of activation. 
We note that we largely did not recover the motifs recently identified in a subset of 7 of 
the 19 cell lines (Song et al. 2011). In contrast to this study, which used the sequences 
from cell-type specific DHS as foreground and the subsets of cell-type specific DHS in 
other cell types as background, we analyzed the sequences from all DHS associated to a 
gene, and defined the background according to the classification tasks .  
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Table 6: Matches to motifs identified using MEME. 
 
Motifs were first compared to the top10 non-redundant TFs using STAMP. The 
matches found to that list are shown in bold. * indicates that the TF also was identified in 
the classifier as being predictive.  
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3.3.7 Footprints in DNase-seq data show evidence of direct TF 
binding 
While we have shown that the presence of sequence motifs in DHS regions is 
predictive of cell-type specific gene expression patterns, we were only able to validate 
the direct binding of two factors due to the lack of ChIP data. This issue is likely to arise 
in several studies where ChIP data is not available to provide evidence of direct binding 
of a TF to its cognate binding site. However, if a region is bound by a TF, the profile of 
aggregate reads around the TF binding site will show that region to be protected from 
digestion by DNaseI, resulting in a DNase ‚footprint‛. Based on this pattern, DNase-seq 
data has been recently used to identify the precise binding locations of several TFs at 
base pair accuracy (Hesselberth et al. 2009; Boyle et al. 2011; Pique-Regi et al. 2011).  
To assess whether the factors that had high regression coefficients in the 
classification tasks showed such distinctive footprints, we compiled the DNase-seq reads 
in a 100bp window centered on the top motif matches across the genome. We expected 
to see a distinct pattern in the cell line in which a motif was predictive of gene 
expression. As a control, DNase profiles were compiled for cell lines in which the model 
did not have a high regression coefficient for the TF. The motif matches used here were 
chosen to reflect the genome-wide binding of the factor, as opposed to the specific 
binding sites used to model gene expression. 
For several factors, we observed indicative footprints in the region of the motif 
(Figure 13). For example, CRX was predictive of UR genes in the medulloblastoma cell 
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line, and it exhibited a protected region at the motif (Figure 13A). Importantly, in other 
cell lines such as GM12878, LnCAP and MCF7, the CRX motif did not display a similar 
level of protection. While CRX has been shown to be expressed in certain types of 
medulloblastoma sub-types (Kool et al. 2008), other factors such as OTX2 have nearly 
identical PWMs and are known to be important for transcriptional regulation in 
medulloblastomas (Bunt et al. 2011). This highlights a caveat in predicting expression 
from motifs; while we can identify biologically relevant motifs, this type of analysis only 
suggests a subset of factors that likely bind to a specific motif.  
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Figure 13: Aggregate plots of DNase-reads around motifs for factors with high 
regression coefficients. 
 (A) CRX shows a footprint in medulloblastoma but not in the other cell lines 
shown. (B) REST shows a footprint in other cell lines but not in medulloblastoma where 
it is not expressed. (C, D) EGR2 and SPIB show footprints in GM12878 cell line. Red 
lines indicate the cell line in which TF is identified as a regulator. 
 
 94 
 
As mentioned earlier, we identified REST as a regulator in the medulloblastoma 
cell line. Since it is not expressed in this cell line, we observed the absence of a footprint 
in that cell line, and a visible footprint in other cell lines (Figure 13B). Additional 
footprinting evidence is detected for EGR2 and SPIB in the GM12878 cell line (Figure 
13C-D); however, the SPIB motif also exhibits a smaller footprint in other cell lines. This 
could be due to expression of other factors that bind to a similar motif in this cell line. 
Further work is needed to rigorously quantify these encouraging observations.  
 95 
 
3.4 Discussion 
In this study, we proposed a new method to predict gene expression by using 
DNase-seq data from 19 human cell lines.  Unlike other strategies that require multiple 
ChIP-seq datasets for highly informative regulatory factors, a single DNase-seq 
experiment identifies most regions of the genome that are accessible to TF binding.  We 
show that motifs located in these DHS sites are predictive of cell-type specific 
expression.  
Some of the predictive motifs we identified were found to be enriched within 
cell-type specific DHS in a previous study using a subset of the cell types used here 
(Song et al. 2011). Patterns of co-occurrence and conservation of TFBS have also been 
used to identify regulatory modules de novo (Aerts et al. 2003; Sharan et al. 2003; Fu et al. 
2004; Gotea and Ovcharenko 2008). However, our approach differs from such motif 
finding approaches, as it is not based on the sole presence of motifs, but their predictive 
value for gene expression patterns. As a result, the regression coefficients in our 
classifier and the expression profile of the TF can be viewed as testable predictions of the 
activating or repressing nature of the regulatory interactions between TFs and the 
different patterns. We also do not restrict our analysis here to cell-type specific DHS to 
allow for the possibility that a motif could be present in a region of ubiquitously open 
chromatin, but only be predictive of gene expression in a specific cell type, for instance, 
due to the cell-type specific expression of the factor binding to it. 
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CpG islands are hallmarks of unmethylated regions in vertebrate genomes and 
are known to overlap promoter regions, in particular in constitutively expressed genes 
(Yamashita et al. 2005; Carninci et al. 2006). Our results here are in agreement with 
previous findings that normalized CG dinucleotide content is negatively correlated with 
the specificity of gene expression. Consequently, constitutively expressed genes show 
higher CG content than up-regulated genes. While this feature is therefore useful in 
differentiating constitutively expressed genes, it is a confounding feature of proximal 
promoters when defining tissue specific regulatory codes. Our models are based on 
normalized binding site scores in a compendium of proximal and distal regulatory 
regions, and thus show consistent performance across different expression patterns. The 
classification performance we achieved when using the presence of motifs from open 
chromatin regions is significantly better than using the proximal promoter region. This 
is the case even when CG content is included as a feature for the classifier. We note that 
while using conserved regions of the genome improved the performance of the classifier 
over that achieved with the proximal promoter region, scanning for motifs in open 
chromatin regions still provided the best performance. Interestingly, in a previous study, 
only 43% of DHS were found to overlap an evolutionarily conserved region (Boyle et al. 
2008a) and it is known that functional enhancers are sometimes weakly conserved (Blow 
et al. 2010). 
A related recent study monitored expression using transient transfection assays 
for several promoters (Landolin et al. 2010). The authors then used sequence features in 
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the transfected plasmids to predict expression with high accuracy. There are two main 
differences between this work and our study reported here. First, as pointed out by 
Landolin et al., the promoters are not in their endogenous context in the plasmid. 
Therefore, this effort reflects the role sequence plays in determining expression outside 
the chromatin context. In contrast, our work attempts to identify cell-type specific 
expression from the endogenous accessibility of putative cis-regulatory regions. Second, 
the authors defined classification tasks different from the ones we examined here. In 
particular, they discriminated cell-type specifically expressed genes from ubiquitously 
expressed and unexpressed genes. While the first classification task is similar to the UR 
vs. constitutive classifiers here, we do not attempt to define ubiquitously unexpressed 
genes, as genes could always be expressed in another condition not assayed, or be 
affected by artifacts such as ineffective probes or mis-annotated genes. On the other 
hand, we build classifiers for the harder problem of predicting up- or down-regulation 
in one cell type versus another.  
As expected, we observed an increased performance when using the 
comprehensive set of all PWM scores rather than just those for the most specifically 
expressed TFs. However, these models are harder to interpret: many PWMs used to 
compute the comprehensive feature vectors are highly similar or identical. TFs with the 
same protein binding domains also have similar binding preferences, and a large 
proportion of the TFs in the current release of the UniProbe database are homeodomain 
TFs. This can lead to collinearity among the features that are used to classify the genes 
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into different sets. As a result, over multiple iterations of the cross-validation, the 
weights assigned to each PWM are distributed to similar PWMs, and comparatively few 
PWMs had significant regression coefficients. To counter this, we used the subset of 
specifically expressed TFs, where our modeling approach allowed us to identify several 
known TFs that regulate gene expression but also additional candidates to study for 
their potential role in gene regulation in the given cell type. Future efforts will make use 
of recent sparse regression models that explicitly account for feature redundancy, or use 
projection methods such as factor analysis to explain the high-dimensional feature 
vectors by smaller numbers of covariates.  
DNase data also showed footprints of cell-type specific binding of some factors 
at a high resolution. This analysis therefore corroborates recent analyses that 
demonstrated that the DNase-seq assay improves the signal-to-noise when attempting 
to identify functional locations of TF binding (Boyle et al. 2011; Pique-Regi et al. 2011). 
Future work in predicting gene expression will attempt to understand the utility of this 
high-resolution data in predicting gene expression. 
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4. A fine time course expression analysis identifies 
transcriptional cascades and a putative regulator of sex 
determination 
4.1 Summary 
The commitment of a bipotential gonad to differentiate as a testis or an ovary is 
governed by a dynamic transcription network that remains to be elucidated. We profiled 
genome-wide gene expression at <5hr resolution during the critical one-day 
developmental window in XX and XY mouse gonads from the 129S1/SvImJ and 
C57BL/6J strains. We identified cascades of expression in both strains and show that 
establishment of dimorphic expression is largely due to activation and repression 
programs initiated by the testis pathway. Strikingly, comparison of expression 
differences between the two strains revealed a delay in the male program in C57BL/6J 
gonads, suggesting an explanation for the increased susceptibility to male-to-female sex 
reversal exhibited by this strain. Finally, we exploit the predictive power inherent in this 
temporal dataset to identify a novel candidate gene, Lmo4, underlying an expression 
QTL identified in a previous study. Confirming our prediction, knockdown of this gene 
in primary XY gonad cells resulted in the down-regulation of several male program 
genes. Our results highlight the importance of fine-scale resolution time-course 
measurement of expression in developmental systems to identify candidate regulatory 
genes and to understand general properties of the system. 
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4.2 Introduction 
To improve our resolution of the transcriptional cascade controlling sex 
determination, and choose attractive candidates in eQTL intervals, we conducted a fine 
time course transcriptome analysis of the gonad between E11.0-E12.0, when the 
bipotential gonad approaches a decision point, initiates the testicular or ovarian 
pathway, and begins to reinforce the sexual fate decision. We profiled global gene 
expression at six equally-spaced intervals in XX and XY gonads from the susceptible B6 
and resistant 129S1 strains, developed and trained a Hidden Markov Model (HMM) to 
discern the onset of sexually-dimorphic expression, and identified gene cohorts 
activated or repressed specifically in the testis or ovary during this brief 24-hour 
window of development. Specifically, we assayed total transcript abundance in XY and 
XX gonads at six equally spaced intervals between E11.0-E12.0 (Figure 14). By 
comparing the onset profiles of both strains, we found that susceptibility to sex reversal 
in B6 XY gonads is likely due to the delayed activation of many testis pathway genes 
and delayed repression of many ovarian pathway genes. We exploited this detailed 
view of the B6 and 129S1 gonad transcriptomes to prioritize candidate regulatory genes. 
Finally, we developed a primary cell validation assay and lentivirus-based shRNA 
delivery method to artificially silence Lmo4 (Lim-domain only 4), a candidate regulatory 
gene within an eQTL interval. We provide strong evidence that Lmo4 is a novel regulator 
of sex determination upstream of many sex-associated genes. This work provides a 
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systematic framework for predicting and testing regulatory genes (eQTGs) underlying 
eQTLs that is applicable to other systems. 
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Figure 14: Experimental design for profiling the gonad transcriptome during 
the 24-hour period encompassing sex determination. 
Total transcript abundance was profiled in XX and XY gonads at six equally spaced 
intervals between E11.0-E12.0 capturing the critical transition in the gonad 
transcriptome from a bipotential to sexually-differentiated state. The analysis was 
conducted in two inbred strains, C57Bl/6J (B6) and 129S1/SvImJ (129S1), with well-
characterized differences in their sensitivity to sex reversal. 
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4.3 Results 
4.3.1 Dynamic transcriptional changes are observed as the 
bipotential gonad differentiates to a testis and ovary 
Total transcript abundance was measured by microarray for individual pairs of 
gonads for each sex/strain/stage combination (n = 74 total arrays). A total of 9,254 genes 
(12,213 probes) exhibited significant expression above background in at least two 
replicates of one sample type, and were included in subsequent analyses (Figure 15). 
Next, we fit a linear model accounting for the effects of strain, sex, stage, and two-way 
(e.g. sex*stage) and three-way (e.g. sex*stage*strain) interactions among these factors 
(Figure 16). For more than half (n = 4,752 (5,659 probes)) of the genes that passed our 
filtering criteria, a significant proportion of the observed variation in expression could 
be attributed to one or more experimental variables (Figure 15). The individual 
components of sex (n = 1,172 genes/ 1,343 probes), stage (n = 2,434 genes/ 2,805 probes), 
and strain (n = 3,279 genes/ 3,879 probes), as well as the interaction effect of sex by stage 
(n = 659 genes/ 733 probes), all had significant effects on the expression of hundreds to 
thousands of genes. For many of these genes, expression was influenced by the additive 
effects of multiple components (probes in overlap regions in Venn diagram, Figure 15). 
Moreover, the sex by stage interaction effect reflects the number of genes that have a 
sexually-dimorphic pattern of expression that changes over time in the E11.0-E12.0 
window. Finally, the large number of genes with a strain effect highlights the extent to 
which the transcription programs vary in the B6 and 129S1 strains. These data illustrate 
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both the complexity and dynamic nature of the transcriptional program driving sex 
determination during this brief but critical developmental window.  
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Figure 15: Analysis of Variance (ANOVA) identifies genes showing significant 
variation by strain, sex, stage and their interactions 
Nearly half of the probes on the array (n = 12,213), representing more than half of 
all genes (n = 9,254, shown in gray), were expressed above background levels at one or 
more time points between E11.0-E12.0 in XY or XX gonad samples. For a large 
proportion of expressed probes (n = 5,659), variation in gonad transcript abundance was 
significantly associated with additive effects from sex, developmental stage, and/or 
strain. A sex-by-stage interaction effect accounted for a significant proportion of the 
expression variation in 733 probes.  For many probes, variation in expression is driven 
by more than one experimental variable. A Venn diagram (Right) showing probes 
whose expression is affected by one or more of the additive effects of sex, stage, and 
strain. Values within each circle correspond to the number of probes that are 
significantly affected by that variable. Note that the overlaps in the Venn diagram do not 
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capture interaction effects, but represent probes that are significantly affected by two or 
all three factors.  
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Figure 16: Examples showing significant difference in expression for each of 
the variables in the ANOVA analysis.  
(A) Sex effect (Ddx3y): XY gonads show higher expression than XX gonads. (B) 
Stage effect (Ltbp4): Expression is higher at later time points across strains and sex. (C) 
Strain effect (Myo6): 129S1 mice show higher expression regardless of sex and stage. (D) 
Sex-by-stage effect (Gstm1): XY gonads show higher expression starting at E11.6. (E) Sex-
by-strain effect (Xist): B6 XX gonads show higher expression compared to 129S1 XX 
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gonads. (F) Stage-by-strain effect (Ptpro): B6 gonads show higher expression at later 
stages. (G) Sex-by-stage-strain (Hapln3): 129S1 XY gonads starting at E11.8 show 
significantly different expression compared to all other sample types. 
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4.3.2 Developing a Hidden Markov Model to identify cascades of 
expression 
To identify ordered cascades of expression and co-regulated genes, we 
developed a Hidden Markov Model (HMM) (Figure 17). HMMs are well-suited to the 
task of discerning patterns in time series data (Schliep et al. 2003; Yuan and Kendziorski 
2006) because they use correlations between adjacent time points to overcome noise and 
increase sensitivity. Briefly, the HMM was designed with 18 states, three per time point 
– a male (i.e. testis-enriched) state, a female (i.e. ovary-enriched) state, and a similar 
expression state (Figure 17, Figure 18). The fold difference of a gene’s expression 
between XX and XY gonads at each time point was used to train the HMM. After 
training the model, the Viterbi state path of each gene reflected whether the gene was 
expressed in a sexually dimorphic fashion, the sex in which it was expressed more 
highly, and the times at which the gene exhibited dimorphic expression. Importantly, 
only 22 of a possible 729 state paths through the model were populated (Table 7), 
indicating that despite the highly dynamic changes in the transcriptome, there are 
common expression trajectories by which the expression patterns can be clustered. We 
note that while the HMM classifies genes as becoming dimorphically expressed at 
specific times, this is due to the discrete sampling during the window. In reality, these 
genes are likely to show minor deviation from the specific time points at which we 
identify them as becoming dimorphic. Nonetheless, grouping the genes by their onset of 
dimorphism reveals interesting details of the regulatory programs involved. 
 110 
 
 
 111 
 
Figure 17: A Hidden Markov Model (HMM) to identify patterns of dimorphic 
expression in the gonad transcriptome.  
Fold differences between XY and XX gonads at each time point in both strains 
were calculated for all probes passing the ANOVA filtering step. This data was then 
used to initialize and train the Hidden Markov Model (HMM) (see Methods). The most 
probable (Viterbi) state path reflects possible dimorphic expression patterns between XX 
and XY gonads and was used to cluster genes. Heatmaps illustrate 3 clusters with state 
paths indicated by circles at the top of each heatmap. 
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Figure 18: State transition and emission probabilities of the Hidden Markov 
Model before and after training 
 
(A) State transition probabilities for the HMM (Figure 17) after (before) training 
with the Baum-Welch algorithm. Numbers in the E11.0 column show probability of a 
gene’s expression starting in the male, female or similar expression state after (before) 
training. Transition probabilities are shown for each pair of transitions from one time 
point to the next for E11.2-E12.0. Colors of the cells indicate the state at that time point. 
First three rows in each column show transition from a male state at the previous time 
point, the middle three show transition from a similar expression state and the last three 
rows show transition from a female state at the previous time point. For example, after 
training, the probability of transitioning from a similar expression state at E11.6 to a 
male expression state at E11.8 is 0.06.  (B) State emission probabilities for the three states 
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before (left panels) and after training (right panels). Emission probabilities for 
discretized fold changes were initialized by hand. After training, emission probabilities 
still reflect the intuitive meaning of the states. For example, higher expression in XY 
gonads is likely to be observed in emissions from the male state. Emission probabilities 
for the states were tied across time points.  
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Table 7: Numbers of genes (probes) in each Viterbi state path identified by the 
HMM for both 129S1 and B6 mice. 
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Each state path has six states, one for each time point, and genes having the same 
state path are clustered together. Only 3 genes switch from showing higher expression 
in one sex to higher expression in the other. Most genes that become dimorphic continue 
showing dimorphism throughout the E11.0–E12.0 window. 
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4.3.3 Identifying sequential cascades of expression by onset of 
dimorphism 
Out of the 4,752 genes included in the analysis, 1,321 genes exhibited dimorphic 
expression at one or more time points between E11.0-12.0 in the 129S1 strain and similar 
numbers (1,037 genes) were dimorphically expressed in the B6 strain (Table 7). 
Interestingly, for both 129S1 and B6, once a gene established a dimorphic expression 
pattern, most continued in a state of sexually dimorphic expression until E12.0 (n = 1,254 
genes for 129S1, n = 995 genes for B6). We refer to these genes as male- or female-
enriched depending on which sex exhibited higher expression. Finally, only three genes 
(Lefty2, Mcm6, and LOC233529) in 129S1 (and none in B6) switched from being more 
highly expressed in one sex to the other during the duration of our window.  
We used the HMM to cluster male- and female-enriched genes by the time of 
onset of dimorphic expression from E11.2 to E12.0 for the 129S1 strain (Figure 19). This 
analysis revealed striking cascades of sexually-dimorphic male and female enrichment 
with the number of male- and female-enriched genes gradually increasing across time 
points. For example, for male-enriched genes a single gene (Sox9) showed higher 
expression in males starting at E11.2, followed by 30 genes at E11.4, and finally 202 
genes that showed sexually dimorphic expression at E12.0 (Table 7). To determine 
whether these cascades primarily reflected changes in one gonadal cell type or several, 
we compared our whole gonad data with cell type-specific gene expression data from 
E11.5 and E12.5 isolated XX and XY supporting cells and germ cells (Jameson et al. 
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2012b). We found that the overlap with germ cells was low (5%). In contrast, 58% of 
genes that became male- or female- enriched in our whole gonad transcriptome prior to 
E11.8 were specifically dimorphic at E11.5 or E12.5 in supporting cells. After E11.8, the 
overlap with the supporting cell precursors dropped to 45%. Thus, consistent with 
previous results, the supporting cell lineage, known to be critical for initiating the sex 
determination decision, is responsible for a large proportion of the sexually-dimorphic 
gene expression that arises in the gonad between E11.0-E12.0 (Jameson et al. 2012b).  
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Figure 19: Cascades of dimorphic expression involving both activation and 
repression in XY gonads. 
 (A) Examples of genes showing higher expression in XY (male-enriched genes, 
top panel) and XX gonads (female-enriched genes, bottom panel) from 129S1 mice. Blue 
and red vertical lines show the time of onset of dimorphic expression. (B) Cascades of 
dimorphic gene expression identified by the HMM in XY (top panel) and XX gonads 
(bottom panel). Colors indicate the log fold change between XY and XX gonads at a 
specific time point for the 129S1 strain. The genes are arranged in order of time of onset 
of dimorphic expression. (C) Contribution to changes in expression between E12.0 and 
the time point before the onset of dimorphism are shown for each gene in (B) in XY 
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(column 1) and XX (column 2) gonads. Top panel: male-enriched genes. Bottom panel: 
female-enriched genes. This analysis shows that male-enriched genes are mostly up-
regulated in XY gonads while female-enriched genes are mostly down-regulated in XY 
gonads. (D) Male- or female-enriched genes in whole gonads between E11.0 and E12.0 
are primarily dimorphic in the supporting cell lineage of the gonad in 129S1 mice. The 
cascade of genes that become dimorphically expressed between E11.2 and E12.0 was 
cross-referenced with cell-type specific expression datasets analyzed at E11.5 and E12.5 
(Jameson et al. 2012b). Column 1 shows overlap with genes expressed dimorphically in 
supporting cells while column 2 shows overlap with genes expressed dimorphically in 
germ cells. Rows are colored blue or red where the probe was dimorphically expressed 
and higher in XY cells or higher in XX cells, respectively. The highest overlap is seen 
with the supporting cells for both male- and female-enriched genes. 
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The HMM classified Sox9 as the earliest male-enriched autosomal gene (E11.2), 
reflecting its position directly downstream of Sry in the testis pathway (Sekido and 
Lovell-Badge 2008) and affirming the fine temporal resolution of our dataset. As in 
previous microarray experiments using whole gonad samples (Small et al. 2005), Sry 
was not detected above background levels in the current study. Following the up-
regulation of Sox9, several other known crucial downstream genes such as Fgf9, Amh, 
and Dhh showed increased expression in XY gonads (Figure 19, top panel). In the 
female-enriched group, Wnt4, one of the earliest autosomal genes known to act in ovary 
differentiation (Vainio et al. 1999; Jameson et al. 2012a), was sexually-dimorphic at E11.4. 
Other known female pathway genes such as Fst and Axin2 became differentially 
expressed at the same stage or immediately following the dimorphic expression of Wnt4. 
All the male-enriched genes that were activated prior to Sox9 and female-enriched genes 
enriched prior to Wnt4 are Y- and X-linked genes, respectively (Figure 20 and Figure 21). 
Particularly interesting are the 7 X-linked genes that exhibited higher expression in XX 
gonads starting at E11.2 (Figure 21). The cell-type specific data indicate that these genes 
are all highly expressed in germ cells and likely reflect the reactivation of the inactive X 
chromosome in XX germ cells at this stage (Chuva de Sousa Lopes et al. 2008). 
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Figure 20: X-linked and Y-linked genes that are dimorphically expressed across 
the E11.0 – E12.0 window. 
 (A) Expression of Ddx3y, Eif2s3y, and Jarid1d in 129S1 gonads (blue – expression 
in XY gonads, red – expression in XX gonads). All three genes are Y-linked and are 
expressed higher in XY gonads across the E11.0 – E12.0 window. (B) Expression of Xist, 
Utx, and Eif2s3x in 129S1 gonads. All three genes are X-linked and are expressed higher 
in XX gonads across the E11.0 – E12.0 window. 
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Figure 21: X-linked genes showing higher expression starting at E11.2 are 
germ-cell enriched. 
(A) – (G). (left column) 7 genes showing higher expression in XX gonads in 129S1 
mice, likely due to the higher number of germ cells in 129S1 mice (Western et al. 2011). 
(A) – (G). (right column) Corresponding expression in male (solid line) and female 
(broken line) in germ cells (green) and supporting cells (purple) from cell-type specific 
expression data. Note that 4932441K18Rik expression was not captured in the cell-type 
specific expression dataset. All genes show enriched expression in germ cells.  
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4.3.4 The testis program activates and represses large cohorts of 
genes 
To determine whether activation, repression, or a combination of both was 
involved in primary establishment of dimorphism for each gene, we conducted an 
analysis using the initial and final time points in our time course. We calculated the fold 
change in both XX and XY gonads for each gene between E11.0 and E12.0 in the robust 
129S1 strain. We then graphed these sex-specific fold changes for each gene on an X-Y 
scatter plot, with fold changes in the XY gonad appearing on the Y-axis, and changes in 
the XX gonad appearing on the X-axis (Figure 22). The scatter plot identified genes 
exhibiting male enrichment (Sox9, Dhh, and Cbln1 (Bitgood et al. 1996; Morais da Silva et 
al. 1996)), or female enrichment (Irx3, Wnt4, and Msx1 (Menke and Page 2002; Jorgensen 
and Gao 2005)), are shown adjacent to their locations in the scatter plot. In addition to 
genes with sexually dimorphic expression patterns, we also identified genes that are 
identically-repressed or activated by both the male and female programs (genes on the 
diagonal in Figure 22). We hypothesize that identically-activated genes (e.g. Hoxd10 and 
Hs3st3a1) canalize sexual differentiation regardless of the nature of the fate commitment, 
while genes that are identically-repressed (e.g. Gfra3 or Hoxa7) function during early 
gonad formation to preserve the bipotential state of the gonad. A subset of these genes 
(14, log2(fold change) >0.585 in both sexes) overlaps with the ‚core adrenogonadal 
program‛ previously identified in the related steroidogenic-factor-1-positive cell 
population (Pitetti et al. 2013). 
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Figure 22: Changes in XX and XY gonads contribute to expression fold change 
between E11.0 and E12.0.  
Gene expression in XY and XX gonads was compared at the beginning and end 
of the 24-hour developmental window. For probes that exhibited a 1.5-fold or greater 
change in expression in either sex between E11.0 and E12.0, log of the Fold Change in 
the XY gonad is plotted on the Y-axis, and log of the Fold Change in the XX gonad is 
plotted on the X-axis. Probes that are similarly up-regulated or down-regulated in both 
sexes appear in gray in the upper right and lower left quadrants, respectively. Probes 
that become enriched in XY gonads relative to XX are shown in blue, while genes that 
become enriched in XX gonads relative to XX are shown in red. Examples from each 
category are highlighted, and their expression patterns in XY (blue line) and XX (red 
line) gonads are displayed.  
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This view of sexually dimorphic expression changes between E11.0 and E12.0 
also revealed that higher expression in one sex can result from activation in one sex (e.g. 
Dhh in Figure 22), repression in the other sex (e.g. Msx1), or a combination of both 
mechanisms (e.g. Wnt4). From the scatter plot, it is evident that dimorphic expression of 
most genes (202 genes, log2(fold change) > 0.585) expressed higher in the testis occurred 
primarily through activation, with a small outlier group of genes (24 genes, log2(fold 
change) < -0.585) showing dimorphism as the result of repression in the XX gonad. 
Among genes showing higher expression in XX gonads, two principal gene clusters 
were evident: members of one cluster (76 genes) achieved dimorphism primarily 
through activation in the XX gonad, and members of the other (147 genes), primarily 
through repression in the XY gonad. This indicates that the dynamic expression changes 
observed during gonad fate commitment are a result of the action of activation and 
repression programs. 
Note that the analysis of the scatter plot does not take into account changes in 
expression initiated at the onset of dimorphism. To do so, we compared gene expression 
in each sex before the initiation of differential expression and the E12.0 stage (Figure 
19C). For all genes that showed higher expression in the XY gonad by E11.8, 73% of 
genes (256 genes) were strongly activated (log2(fold change) > 0.32, p < 0.05) in XY 
gonads, whereas only 9.5% (34 genes) were repressed in the XX gonad (log2(fold 
change) < -0.32, p < 0.05). In addition 5.6% (20 genes) become dimorphic through a 
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combination of activation in XY and repression in XX gonad. This indicates a strong 
activation program in XY gonads with a much lower contribution from repression of 
male pathway genes in XX gonads. In striking contrast, enrichment of genes in XX 
gonads results not from activation in the ovary, but primarily through repression in the 
testis (Figure 19C, lower panel). Only 16% of probes (61 genes) that are female-enriched 
by E11.8 are activated in the XX gonad, while 61% (217 genes) are repressed in the XY 
gonad, with 7.5% (27 genes) becoming dimorphic due to a combination of activation in 
the XX and repression in the XY gonad. In fact, in several cases, Msx1 for example 
(Figure 22), female enrichment stems exclusively from repression taking place in the 
testis. This indicates that in addition to the activation program, a strong repressive 
program is also present in the testis. While male repression of specific female pathway 
genes (Wnt4) has been known, the extent of this repressive signature is surprising. 
 
4.3.5 Activation of the male and repression of the female 
differentiation pathways in the XY gonad are delayed in the sensitive 
B6 strain 
After characterizing the temporal dynamics of XY and XX gonad transcriptomes 
from the 129S1 strain that is resistant to XY sex reversal, we determined how the 
transcriptome varied in B6, a strain that is sensitive to XY sex reversal in response to 
multiple genetic perturbations (Eicher et al. 1982; Bouma et al. 2005; Correa et al. 2012). 
While previous studies showed that male-enriched genes were expressed at a higher 
level and female-enriched genes at a lower level in 129S1 compared to B6 E11.5 XY 
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gonads (Munger et al. 2009), it was not clear whether this strain difference was a result 
of the difference in expression levels, time of onset, or a combination of both. To address 
these questions, we profiled global gene expression in XY and XX gonads from B6 at the 
same six time points spanning the critical 24-hour window (E11.0-E12.0). We then used 
the HMM to identify male- and female-enriched genes in B6 mice (Figure 23). In good 
agreement with the data from 129S1 mice, these genes showed activation and repressive 
programs in XY gonads, and were strongly biased toward dimorphic expression in 
supporting cells. 
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Figure 23: Detailed characterization of dimorphic expression in B6 gonads 
reveals properties similar to 129S1 gonads. 
 (A) Examples of genes showing higher expression in XY (male-enriched genes, 
top panel) and XX gonads (female-enriched genes, bottom panel) from B6 mice. Blue 
and red vertical lines show the time of onset of dimorphic expression. (B) Cascades of 
dimorphic gene expression identified by the HMM in XY (top panel) and XX gonads 
(bottom panel). Colors indicate the fold difference between B6 XY and XX gonads at a 
specific time point. The genes are arranged in order of increasing time of onset of 
dimorphic expression. (C) Contribution to changes in expression between E12.0 and the 
time point before the onset of dimorphism are shown for each gene in (B) in XY (column 
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1) and XX (column 2) gonads. Top panel: male-enriched genes. Bottom panel: female-
enriched genes. This analysis shows that male-enriched genes are mostly up-regulated 
in XY gonads while female-enriched genes are mostly down-regulated in XY gonads. 
(D) The cascade of genes dimorphically expressed was cross-referenced with cell-type 
specific expression datasets analyzed at E11.5 and E12.5 (Jameson et al. 2012b). Column 
1 shows overlap with genes expressed dimorphically in supporting cells while column 2 
shows overlap with genes expressed dimorphically in germ cells. Rows are colored blue 
or red where the probe was dimorphically expressed and higher in XY cells or higher in 
XX cells, respectively. As with 129S1 gonads, the highest overlap is seen with the 
supporting cells for both male- and female-enriched genes in B6 gonads. 
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We then compared the timing of onset of sexually dimorphic gene expression 
between 129S1 and B6 (Figure 24). We observed a clear, consistent temporal shift in the 
onset of sexually-dimorphic expression in many genes in the susceptible B6 strain 
(Figure 24A, B). Specifically, for male-enriched genes, a comparison of strain onset 
distribution profiles revealed a statistically significant ~5-hour delay in B6 relative to 
129S1 (Figure 24C, upper panel). For example, 208 probes became enriched in 129S1 XY 
gonads relative to XX starting at E11.6 (Figure 24B). When the same probes were 
examined in the sensitive B6 strain, only 37 became dimorphic at the same stage, while a 
majority (n = 107) became male-enriched ~5 hours later at E11.8. Another 20 from this set 
did not become dimorphic in B6 until E12.0, and 35 probes that were male-enriched in 
129S1 at E11.6 failed to become sexually-dimorphic in B6 by E12.0. Even in the case of 
genes that became male-enriched at the same time point in B6 and 129S1, a comparison 
of XY v. XX fold difference at the onset of dimorphism indicated that a majority of these 
genes (65.6%) show a higher male v. female fold difference in 129S1 than in B6 (Figure 
25A, Binomial test p-value < 0.005). This difference may reflect a more robust activation 
mechanism driving the male differentiation pathway in 129S1, or it could reflect a delay 
in expression onset in B6 that is less than ~5 hours and therefore smaller than the 
minimum resolution threshold of this analysis. 
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Figure 24: Dimorphic expression of multiple male- and female-enriched genes 
in B6 is delayed compared to 129S1 mice. 
 (A) Expression of male- (top panel) and female-enriched (bottom panel) genes. 
Dimorphic expression for these genes is delayed by ~5 hours in B6 compared to 129S1. 
(B) Heatmap showing dimorphic expression at E11.6 in 129S1 and comparison of same 
genes in B6. While a few genes show earlier dimorphic expression in B6 mice compared 
to 129S1, the dominant pattern shows a ~5 hr delay between B6 and 129S1 mice. (C) 
Matrix showing the time of onset of dimorphism in 129S1 and B6 mice for male-enriched 
(top panel) and female-enriched (bottom panel) genes. For example, out of the 32 male-
enriched probes that became dimorphically expressed at E11.4 in 129S1, 9 probes were 
also dimorphically expressed starting at E11.4 in B6 while 18 showed dimorphic 
expression starting at E11.6 in B6 mice. However, 4 genes are dimorphic in B6 XY 
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gonads at E11.4, but not in 129S1 until E11.6. * indicates significant overlap with p < 
0.001 evaluated by a hypergeometric test. The highlighted diagonals show the number 
of genes showing similar onset of dimorphism in 129S1 and B6 mice. Note that some 
genes that are male- or female-enriched in one strain do not show dimorphism in the 
other strain. 
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Figure 25: Robust onset of dimorphism in 129S1 mice compared to B6 mice 
(A, C) Scatterplot showing XY vs. XX fold difference (A) and XX vs. XY fold 
difference (C) at the onset of dimorphism for male- and female-enriched genes that are 
activated at the same stage. Fold difference between 129S1 XY and XX gonads at the 
onset of dimorphism are plotted on the y-axis and the fold difference between B6 XY 
and XX gonads at the onset of dimorphism on the x-axis. Onset of dimorphism is more 
robust in the 129S1 strain for both male- and female-enriched genes. (B) Sox9 becomes 
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dimorphic at E11.2 in 129S1 and B6 gonads. However, the fold difference between XY 
and XX gonads is higher at E11.2 in 129S1 mice.  
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Importantly, this delayed onset pattern of male-activated genes in B6 does not 
appear to stem from a difference at the top of the cascade in Sry expression level during 
this critical window. Although Sry was not detected above background in these arrays, 
there was no significant difference in expression levels between 129S1 and B6 between 
E11.2-E12.0 by qRT-PCR (Figure 26A). It should be pointed out that the high variability 
in Sry abundance observed among individual pairs of XY gonads could mask a small 
but real strain effect for Sry expression levels. In contrast, Sox9 is more robustly up-
regulated in 129S1 relative to B6 (Figure 25B), an observation we confirmed by qRT-PCR 
(Figure 26B). By E11.8 expression of Sox9 in B6 XY gonads has caught up with 
expression in 129S1. Some of the delay in onset of male-enriched genes at later stages in 
B6 may be due to this initial deficiency in the robustness of Sox9 activation. 
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Figure 26: 129S1 and B6 XY gonads show no significant difference in Sry 
expression but a small difference in Sox9 expression as assayed by qRT-PCR 
(A) Sry expression levels are similar in 129S1 and B6 XY gonads between E11.2-
E12.0. No statistically significant (p < 0.1) differences are detected at any time point in 
this analysis, however high variability among individuals may mask a small but 
biologically meaningful strain effect for Sry transcript abundance in this window. (B) 
Sox9 expression shows significantly different expression (p < 0.1 (*) and p < 0.05 (**)) at 
the 17, and 18 tail somite stage.  
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Note that the delayed onset pattern was not observed for every gene that became 
male-enriched over this 24-hour period. For example, of the 208 probes that were male-
enriched starting at E11.6 in 129S1, a few (Gstm2, Etv5, Gas7, and Mybphl) became 
sexually-dimorphic earlier in B6. Similarly, of the 75 genes that showed male-enrichment 
in B6 at E11.6, 11% (n = 8, including Schip1, Lpl, Socs2) become male-enriched later in 
129S1 or not at all before E12.0. This indicates that although much of the male 
differentiation pathway is delayed in B6, this pattern is unlikely to be due to a more 
general delay in gonad differentiation. 
Female-enriched genes exhibited a similar significant ~5 hour delay in B6. 
However, this strain delay stems from the later repression of female genes in XY gonads 
(Figure 24B, lower panel). As a consequence, B6 XY gonads are exposed to higher levels 
of female pathway genes for a longer period relative to 129S1 XY gonads. For example, 
of the 166 probes that become female-enriched in 129S1 starting at E11.6, only six exhibit 
a similar expression pattern in B6, while 70 become female-enriched ~5 hours later, 
another 43 probes become dimorphic at E12.0, and 47 fail to reach a sexually-dimorphic 
state by E12.0 (Figure 24C, lower panel). Similar to the male-enriched genes, 62.4% of 
female-enriched genes that become dimorphic at the same time in both strains show a 
higher fold difference in 129S1 than in B6 (Figure 25C, p < 0.005). 
In summary, it is likely that the increased sensitivity of B6 XY gonads to sex 
reversal stems from a delay in the activation of male pathway genes downstream of 
Sox9, combined with a consequent delay in the repression of female pathway genes. 
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4.3.6 Using time course analysis to identify candidate genes in eQTL 
regions 
In addition to providing a more comprehensive view of the global transcription 
dynamics driving male and female sex determination in the robust 129S1 and sensitive 
B6 strain backgrounds, this fine temporal expression data provided a means for 
narrowing eQTLs to identify novel regulators of sex determination. In previously 
published work, we mapped 19 regions of the genome in an F2 intercross population 
where genetic variation between B6 and 129S1 was correlated with differences in gene 
expression for one or more genes associated with sex determination (Munger et al. 2009). 
Eight of these regions were correlated with the expression of multiple genes, yet none of 
these prominent ‚trans-band eQTLs‛ harbored an obvious candidate gene with a known 
role in the sex determination process. Unfortunately, most of the eQTL regions 
identified in this initial coarse mapping were too large to functionally test every gene in 
the interval.  
We established filtering criteria based on temporal strain expression and 
genomic data to prioritize candidate genes within the eight trans-band eQTLs (Table 8). 
Briefly, protein-coding genes in the interval were considered as candidates if they were 
expressed at one or more time points between E11.0-E12.0 in XY samples (eQTLs were 
mapped only in XY samples; therefore, the causative gene underlying an eQTL should 
be expressed in the XY gonad). Based on this list, we analyzed each candidate within the 
interval for strain differences in expression levels or time of onset, and prioritized genes 
with strain-dimorphic patterns. We investigated whether each gene harbored one or 
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more polymorphisms (SNPs, insertion/deletions) that differed between B6 and 129S1 
and might affect its expression or function. Only those genes with characterized 
variation within 10kb up- and down-stream of the transcription start site (TSS) were 
prioritized for further analysis. Finally, we interrogated the Mammalian Phenotype 
(MP) browser to identify any genes in the region with a characterized knockout 
phenotype affecting sex determination (MP: 0002210, abnormal sex determination), or a 
known relationship with any of the target genes it was predicted to regulate. We tailored 
our candidate search strategy to each individual eQTL, and exploited prior information 
about the expression or function of the target genes for that region. Thus, we expected 
that genes involved in regulating early gonadogenesis genes would be expressed in both 
sexes at an early stage, whereas those regulating the male or female pathway would be 
more likely to exhibit sexually dimorphic gene expression.  
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Table 8: Identification of candidate genes in prominent trans-band eQTLs 
based on dynamic expression patterns 
 
Multiple criteria were established to identify the best candidate genes in the 
trans-band eQTLs mapped previously. First, the putative regulatory gene must be 
expressed above background at or before E11.5 to exert any effects on downstream 
target genes. Genes implicated in the list of target genes that exhibited a sexually-
dimorphic expression pattern consistent with the sexual differentiation pathway (male 
or female) were prioritized. Genes that met both of the above criteria, and exhibited 
strain expression differences (either in overall levels of transcript abundance or in timing 
of onset of sexual dimorphism) in a pattern consistent with the observed allelic effects 
for that eQTL, were prioritized as the highest candidates. A few eQTLs harbor genes in 
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which abnormal sex determination phenotypes have been noted in the null mutant 
mouse, and these genes were given similar high priority.  
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In total, for the eight prominent trans-band eQTLs mapped, of which the average 
interval contains ~300 genes (range = 60-526 genes), we narrowed each down to, at most, 
eight promising candidates. Of particular interest, the distal Chr 3 region was strongly 
associated with the expression of nearly one-third of all the genes in our previous 
mapping study , including known regulators of early gonadogenesis (Fog2/Zfpm2, 
SF1/Nr5a1, Gata4, Wt1, and Ctnnb1) and both the female (Ctnnb1, Rspo1) and male (Fgf9) 
differentiation pathways. A total of six genes were identified as candidates based on 
their strain-dimorphic expression patterns, but only the transcription cofactor Lmo4 (lim 
domain only 4) exhibited a dynamic pattern consistent with a role early in both 
pathways and an additional male-specific role downstream of the sexual fate decision. 
Lmo4 is expressed at similarly high levels in both sexes until E11.4 (Figure 6A), and 
becomes male-enriched as early as E11.6.  Importantly, while Lmo4 was up-regulated in 
B6 XY gonads at the same time as in 129S1, there was a significant strain effect with 
expression in 129S1 being higher. This observation is consistent with the observed allelic 
effect for the eQTL (B6129SF2 gonads that were homozygous for the 129S1 allele 
exhibited higher expression of target genes). Finally, there is a significant amount of 
genetic variation in Lmo4 between 129S1 and B6, including an insertion in the 3’ UTR in 
129S1 as well as multiple intronic SNPs and indels (Keane et al. 2011). Based on these 
selection criteria, we elected to focus on developing a functional assay for Lmo4. 
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Figure 27: Validation of Lmo4 as a novel regulator of gene expression in the 
fetal gonad. 
(A) Lmo4 exhibits an expression pattern indicative of a role in sex determination 
and consistent with expectations for a gene underlying a strain eQTL regulating early 
sex determination and male pathway genes. It is expressed at similar levels in XY and 
XX gonads before E11.6, becomes enriched in XY gonads as early as E11.6 in both 
strains, and shows reduced expression levels in B6 (dashed lines), consistent with the 
observed allelic effects of the Chromosome 3 eQTL. (B) E12.5 XY gonads were dissected 
free of the mesonephroi, pooled by sex, dissociated into single cell suspensions, plated 
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on tissue culture plates at t=0 with lentiviral particles containing shRNA targeted to the 
candidate gene of interest, and cultured for 72 hours. Quantitative RT-PCR was 
conducted to assay expression of predicted targets. (C) Lentiviral shRNA-mediated 
knockdown of Lmo4 in cultured XY primary gonadal cells resulted in the consistent 
down-regulation of multiple Chromosome 3 eQTL target genes relative to the non-
targeting control (gray bar) using two different shRNA hairpins targeting Lmo4 
(light/medium blue bars in graph). Expression was normalized to the housekeeping 
gene Gapdh. Both male pathway genes, Fgf9 and Col9a3, were significantly down-
regulated following Lmo4 knockdown with both clones. Similarly, one of the putative 
targets with a role in early gonadogenesis, SF1/Nr5a1, was significantly reduced, 
however expression of the other gene involved in early gonadogenesis, Wt1, was not 
significantly affected by Lmo4 knockdown. The important male pathway 
regulator Sox9 was found to be significantly down-regulated as a result 
of Lmo4 knockdown. Canx (a second normalization gene not predicted to be a target of 
LMO4) showed no difference in expression compared to the control. Error bars show 
minimum and maximum expression. Significance was calculated by comparing control 
and data across all independent runs. 
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4.3.7 Validation of Lmo4 as the causative gene underlying the trans-
band eQTL on distal Chromosome 3. 
Historically, moving from a list of candidate genes to a validated quantitative 
trait gene (QTG) has represented the largest hurdle (in both resources and time) to 
success in complex trait mapping studies in the mouse. To address this problem, we 
optimized a lentivirus-mediated shRNA delivery method to artificially silence candidate 
regulatory genes with high efficiency in dissociated gonad primary cells from E12.5 XY 
gonads (Figure 27B).  As a positive control, we utilized pre-designed and validated 
shRNA clones (Sigma MISSION) packaged in lentiviral vectors to silence Sox9 
expression in primary gonadal cell culture, and quantified the expression of known 
downstream targets (Figure 28). Lentiviral-mediated knockdown resulted in a nearly 
80% reduction in Sox9 expression relative to a non-targeting control sample. Two of the 
three known targets (direct or indirect) of SOX9, Amh (De Santa Barbara et al. 1998) and 
Fgf9 (Kim et al. 2006), were down-regulated significantly following Sox9 knockdown. 
Ptgds, the third known target of SOX9 (Wilhelm et al. 2007), is not expressed at high 
levels in cultured gonad primary cells, and we could not detect a change in Ptgds 
expression following Sox9 knockdown. However, a marker of the female pathway, Fst 
(Yao et al. 2004), showed a significant and greater than 2-fold up-regulation in this assay 
(p < 0.016). Thus, this in vitro assay recapitulates well-characterized genetic interactions 
that occur in the gonad in vivo. 
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Figure 28: Lentiviral mediated knockdown of Sox9 in gonad primary cell 
culture results in down-regulation of male-enriched genes. 
Knockdown of Sox9 resulted in down-regulation of known male-enriched genes 
such as Amh and Fgf9 and up-regulation of female-enriched gene Fst. However, Ptgds, a 
known male-enriched gene (Wilhelm et al. 2007), does not show down-regulation. 
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We extended our analysis to test Lmo4 as a candidate regulator underlying the 
Chr 3 eQTL. We silenced Lmo4 expression to 36% of a non-targeted control (p < 0.001) 
(Figure 6C).  Although the degree of knockdown was relatively modest, it was observed 
consistently in three independent trials and with two shRNA clones. Importantly, 
silencing Lmo4 expression by two-thirds resulted in the consistent, significant down-
regulation (p<0.05) of three of the four putative eQTL targets measured by qRT-PCR. 
Fgf9, Col9a3, and SF1/Nr5a1 were significantly down-regulated by both shRNAs (Figure 
6C). Down-regulation of a fourth target of the Chr 3 eQTL, Wt1, was not statistically 
significant (p < 0.13). Interestingly, although it was not identified as a Chr 3 eQTL target 
in our original mapping study, Sox9 expression is significantly down-regulated 
following Lmo4 knockdown by both shRNA clones (p < 0.001). Note that the predicted 
targets (Fgf9, Col9a3, and SF1/Nr5a1) of the Chr 3 eQTL region are those that are affected 
by the different alleles in B6 and 129S1. Even though Sox9 did not map as a target of the 
Chr 3 eQTL in our study, it might not be differentially regulated by Lmo4 between B6 
and 129S1, yet could still be a target of Lmo4. In total, these experiments provide strong 
support for Lmo4 as the transcriptional regulator underlying the Chr 3 trans-band eQTL 
and may reveal additional regulatory interactions that were undetected in the eQTL 
mapping study.  
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4.4 Discussion 
4.4.1 Gonadal sex determination is orchestrated by a highly dynamic 
transcriptome 
Previous microarray studies profiled transcript abundance in whole gonads or 
isolated cell populations at two or more time points before and after the sex 
determination decision (Nef et al. 2005; Small et al. 2005; Beverdam and Koopman 2006; 
Jameson et al. 2012b). These datasets served as important resources for the field. 
However, the temporal resolution around the critical stage of sex determination was 
limited in all but one study to 24-hour intervals (Nef sampled at E10.5, E11.0, and E11.5). 
It was evident from these earlier studies that the gonad transcriptome changed very 
little between E10.5-E11.0, that the difference between E11.0-E11.5 was significant, and 
between E11.5-E12.5 the testis and ovarian transcriptomes are highly sexually 
dimorphic. We predicted that information about the sequential order of gene 
activation/repression during the E11.0-E12.0 window would be valuable. Using data 
from the fine time course, we designed an HMM to precisely separate genes based on 
their position in the transcriptional cascade. As opposed to other clustering methods 
such as k-means clustering (Tamayo et al. 1999), HMMs are able to both account for the 
time dependence in the data and exploit this layer of information to identify patterns 
often obscured by noise prevalent in microarray data. We note that this HMM can be 
readily extended to time course expression analyses in other systems. 
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Our analysis identified waves of sexually-dimorphic gene expression in the 24-
hour window following the onset of Sry expression, which suggest regulatory cascades. 
We note that while the HMM identifies dimorphically expressed genes as being 
dimorphically expressed at distinct time points, this is a result of the sampling times of 
our transcriptome analysis. Finer sampling in this window is likely to reveal that genes 
grouped together at a time point show minor differences in timing of the onset of 
dimorphism. Previous work indicated that the supporting cell lineage is the first lineage 
in the gonad to show sexually dimorphic expression followed by other gonadal cell 
lineages after E11.5 (Jameson et al. 2012b). Consistent with this, over half (58%) of the 
genes we identified that became sexually dimorphic prior to E11.8 could be specifically 
assigned to the supporting cell lineage prior to E11.8 with 5% showing dimorphism in 
germ cells. The discrepancies in the overlap are likely due to the increased sensitivity of 
the HMM to identify dimorphically expressed genes and the conservative measure of 
dimorphic expression used in the cell-type specific expression study.   
As expected, we observed a strong signature of gene activation associated with 
up-regulation of the testis pathway in XY gonads. However, we were surprised by the 
extent of the repressive program that silences female pathway-associated genes in the 
XY gonad following activation of the male pathway. Testing of candidates from our 
study will be an important step towards identifying the factors responsible for these 
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patterns of expression in the male and female program. Based on their early onset of 
sexually-dimorphic expression, several genes are promising candidates to play an early 
regulatory role in the male and female pathways. Sox13 is a member of the SOX protein 
family that lacks an activation domain but can repress Wnt signaling by forming a 
complex with the-catenin cofactor, TCF1 (Melichar et al. 2007; Marfil et al. 2010). Mef2c 
is activated in the XY gonad at E11.6 and has been shown to interact with Sox9 in 
chondrocytes (Dy et al. 2012). Among genes that showed female-enrichment, Gtf2a1, a 
general transcription factor that is part of the initiation complex for PolII recruitment 
(DeJong et al. 1995), became dimorphic at E11.4 in the XX supporting cell lineage and 
Tcea3, a known PolII elongation factor became dimorphic at E11.6. Interestingly, female-
enriched TFs such as Zfp277, Runx1, Lef1, Lhx9 and Msx1 were strongly down-regulated 
in XY gonads. Conversely, Irx3 showed strong activation in XX gonads, and has been 
predicted to have a function during ovarian differentiation independent of Foxl2 and 
Wnt4 (Garcia-Ortiz et al. 2009). 
 
4.4.2 Sensitivity to sex reversal in B6 stems from the delayed onset of 
the male pathway downstream of Sox9. 
 Strain differences in resistance to sex reversal upon perturbation of the sex 
determination network have been the focus of several studies. The importance of the 
timing of the antagonistic testis and ovarian programs to B6-associated sex reversal was 
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first proposed by Eicher in 1983 (Eicher and Washburn 1983), based on the finding that 
introduction of a Mus domesticus Y chromosome (YDom, or YPOS) onto a B6 genetic 
background led to sex reversal (Eicher et al. 1982). Sex reversal in this case was later 
shown to be associated with the delayed onset of Sry (Bullejos and Koopman 2005). 
However, this work did not explain why the B6 strain is more susceptible to sex reversal 
in cases where a weak allele of Sry is not involved (Eicher et al. 1996). 
Here we showed that the onset of sexually dimorphic gene expression was 
delayed by approximately five hours in the ‚unperturbed‛ (i.e. wildtype) B6 strain 
compared to 129S1. This delay is consistent across the cascade starting from E11.4 with 
genes that are both up- and down-regulated in XY gonads. Interestingly, we detected no 
significant difference by qRT-PCR in the level of Sry expression between the strains; 
however we cannot rule out a difference in the onset of Sry expression prior to the 
window of our analysis. Nonetheless, Sox9 is up-regulated at the same stage (E11.2) in 
B6 and 129S1. Despite this agreement, the activation of many downstream genes in the 
male pathway is delayed in B6. In our previous microarray comparison of B6 and 129S1 
testes at E11.5 (Munger et al. 2009), Sox9 was found to be enriched in B6 relative to 129S1 
XY gonads at E11.5, in contrast to the current study, where Sox9 levels are lower in B6 
until E11.8-E12.0 (Figure S7B). This discrepancy may stem from small developmental 
staging differences in the pooled gonads used in the previous study, as Sox9 levels are 
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changing very rapidly at E11.5. However, as this and other recent studies (Hiramatsu et 
al. 2009; Correa et al. 2012) illustrate, the system may be sensitive to minor fluctuations 
in gene expression between E11.0-E11.5. Thus, the slightly lower level of Sox9 expression 
that we detected in B6 relative to 129S1 XY gonads might contribute to the delayed onset 
timing of downstream genes in B6. In addition, our fine time course data here helps 
explain the previously observed higher expression of female-enriched genes in B6 
compared to 129S1. Specifically, the observed difference at E11.5 is a consequence of the 
delayed repression of female-enriched genes in B6 XY gonads. 
 
4.4.3 Prediction and validation of Lmo4 as a novel regulator of sex 
determination. 
Previous transcriptome and genetic mapping studies produced gene lists or large 
intervals with candidate regulators of sex determination (Eicher et al. 1996; Nef et al. 
2005; Small et al. 2005; Beverdam and Koopman 2006; Bouma et al. 2007; Nikolova et al. 
2008; Munger et al. 2009; Bouma et al. 2010). The bottleneck in applying the results of 
these studies has been the inability to prioritize between several dozen candidates and 
then test these candidates in a manner that is inexpensive and efficient. We have 
addressed both these deficiencies in the current study. We used our fine time course 
dataset in conjunction with a previous eQTL study and cell-type expression data to 
identify candidate regulators of sex determination.  
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To overcome the hurdle of testing candidate regulators, we developed an RNAi 
assay to silence the expression of candidate genes, and then monitored the expression of 
putative downstream target genes after knockdown. As predicted, shRNA-mediated 
silencing of the transcription cofactor Lmo4 resulted in the down-regulation of known 
important regulators of early gonadogenesis (SF1/Nr5a1) and the male pathway (Sox9 
and Fgf9). This provides strong evidence that in addition to previously characterized 
roles during development in the neural tube (Hahm et al. 2004; Tse et al. 2004; Lee et al. 
2005), neural crest (Ochoa et al. 2012), cortex (Asprer et al. 2011), and thymus (Michell et 
al. 2010), Lmo4 is also a regulator of sex determination in the gonad. However, this does 
not preclude the possibility that other genes on distal Chr 3 have roles during sex 
determination and control the expression of one or more of the 16 eQTL target genes. To 
point, four of the other candidate regulators identified in this region (Gbp1/2/3 and Ccbl2) 
are expressed at similar high levels in both sexes before E11.4, and then become down-
regulated specifically in XY gonads at or after E11.6. This pattern predicts a role for these 
genes in the female differentiation pathway. Future assays to over-express these 
candidates in XY primary cells or silence them in XX primary cells will assess their 
potential as regulators for one or more of the Chr 3 eQTL target genes. 
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5. Setting up ChIP-seq in the gonad 
5.1 Summary 
While being able to conduct ChIP-seq in the gonad would be a crucial step in 
deepening our understanding of the transcriptional regulation that is carried out during 
the fate commitment process, it has been a significantly challenging task. We took a 
methodical approach to solving the problems involved. We started by optimizing the 
sonication settings to produce DNA fragments in the size range between 200-1000bp. We 
then used a mouse myoblast cell line (C2C12) for which ChIP-seq datasets had been 
published, to evaluate the various parameters in the assay, with a focus on using small 
numbers of cells (< 500,000 cells/IP). Finally, we successfully prepared libraries from the 
amounts of DNA we expected to obtain from our ChIP-seq experiments in gonadal cells. 
These steps were crucial in preparing us for conducting ChIP-seq in the supporting cells.  
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5.2 Introduction 
ChIP is a particularly useful technique that reveals where a protein is localized 
on the genome (Furey 2012). This technique has been used across a wide range of 
biological systems to reveal the specific patterns of a variety of DNA binding proteins, 
especially TFs. Given the vast scale of dynamic transcriptional regulation that we 
observe in the gonad as it differentiates to a testis or an ovary, it is extremely important 
that we can understand which regions of the genome drive these patterns of expression. 
However, setting up ChIP in the gonad has been problematic. 
The major steps in ChIP are as follows. First, after samples are collected, proteins 
are cross-linked to DNA, typically with formaldehyde. In some cases, where the proteins 
are tightly bound to the DNA, such as histones, cross-linking has been shown to be not 
strictly necessary (Cuddapah et al. 2009). Second, the cross-linked protein-DNA 
complexes have to be sheared into small fragments between 200-1000bp. This is usually 
accomplished by sonicating the sample in a lysis buffer or treating with the right 
concentration of MNase to shear the chromatin. Note that the smaller the fragment 
length, the higher resolution one has of where the protein is bound. However, the stress 
of excessive sonication or digestion of the sample might lead to the protein not 
remaining bound to the DNA. Therefore, a fine balance between resolution and the 
ability to immunoprecipitate sufficient DNA-bound protein needs to be achieved. Third, 
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the sheared chromatin is incubated with an antibody specific to the protein of interest. 
This could be TFs, histone variants, or proteins with specific post-translational 
modifications, such as histone marks. After sufficient time has been allowed for the 
antibody to bind to the protein, secondary antibodies, that are themselves bound to 
magnetic or agarose beads, are used to capture the primary antibody bound protein 
DNA complexes. Fourth, a series of washes are applied to remove non-specific binding. 
Fifth, the cross-links between the protein and DNA are reversed and the remaining 
protein and RNA are digested with proteinases and RNases, respectively. Finally, the 
DNA is purified using either a phenol-chloroform extraction or a purification column.  
Concurrent to this process different controls are conducted. One control is called 
the input or whole cell extract control. This is collected by simply purifying DNA from 
sheared chromatin without incubation with any antibodies. An alternative control that 
provides a measure of the non-specific binding of the antibodies is the IgG control. The 
IgG antibody is not expected to bind any of the chromatin bound protein and is used in 
exactly the same fashion as the antibody to the protein of interest.  
The steps in this process have to be optimized carefully for different types of cells 
and different antibodies. Specifically, sonication cycles and lysis buffers might have to 
be optimized for different cell types and numbers. Additionally, the antibody amount 
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and the number of washes are important variables that can be tweaked to achieve better 
signal-to-noise ratio in experiments.  
In aiming to set up ChIP-seq in the supporting cells of the gonad, the main 
problem is obtaining sufficient biological material. While typical ChIP assays use ~5M 
cells/IP, FAC-sorts for supporting cells with Sox9-CFP positive male gonads at E13.5 can 
roughly provide ~15,000 cells per embryo. While this already implies that >300 pairs of 
testis have to be collected, the situation is far worse with E13.5 ovaries, with only ~1,500 
supporting cells being FAC-sorted per embryo. Therefore, one requires >3,000 XX 
embryo to be dissected to get enough material to obtain the necessary number of XX 
supporting cells! The situation is even tougher with cells of the bipotential gonad, as the 
dissections of gonads prior to E11.0 are significantly tougher.  
Early attempts at ChIP by a postdoctoral associate, Danielle Maatouk, in the 
Capel lab were focused on identifying the binding sites of beta-catenin, a co-factor that is 
downstream of Wnt signaling. Since, it was observed that Wnt signaling is important in 
ovarian development and that stabilization of beta catenin was at least one of the main 
mechanisms for this effect, understanding the binding locations of the co-factor is an 
important step towards elucidating the role of Wnt4 in ovarian development (Maatouk 
et al. 2008). Using whole female gonads from several embryos, the first step was to 
sonicate the samples to obtain a smear of DNA in the 200-1000bp range. However, 
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despite trying various sonication protocols, including using Bioruptors and probe 
sonicators, the size of the DNA fragments was seen to be consistently above the required 
range of fragments for ChIP experiments. This immediately created hurdles for 
obtaining useful ChIP data and this approach did not bear much fruit. With the benefit 
of hindsight, the reason for the lack of DNA fragments in the required fragment range 
might have been that whole tissue was being used. As a result, the sonication has to 
overcome the extra-cellular matrix of the gonad tissue. Further, the mix of cell types in 
the gonad, each with a different resistance to sonication might have lead to observing 
smears over much larger size ranges. 
An attempt by Danielle Maatouk that proved far more effective was using a 
carrier ChIP protocol for low cell numbers (O'Neill et al. 2006; Rugg-Gunn et al. 2010; 
Zwart et al. 2013). This protocol differs from the standard ChIP protocol in two ways. 
First, MNase digestion is used to shear chromatin in cells that have not been cross-
linked. Second, yeast or Drosophila cells are spiked in to the biological material of 
interest. Following this, species specific primers are designed for the sites of interest to 
identify enrichment by qPCR. The rationale behind adding carrier chromatin is to 
reduce the background observed when one only has a few cells (<1000 cells) to perform 
ChIP. Alternatively, recent protocols have attempted to address the problem of higher 
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background with low sample quantity by optimizing the amount of antibody for specific 
cell numbers (Adli et al. 2010; Adli and Bernstein 2011).  
We set ourselves the goal of developing ChIP-seq to use with supporting cells 
from the gonad. This not only would allow us to answer questions of interest such as 
which regions are active enhancers in supporting cells, but also open a whole host of 
questions that are well suited to be answered by the application of ChIP. In establishing 
this technique, I relied heavily on several recent protocols that were developed with the 
goal of collecting ChIP-seq data from small cell numbers (Dahl and Collas 2009; Adli 
and Bernstein 2011; Sachs et al. 2013).  
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5.3 Results 
5.3.1 Sonication efficiency 
The first step was to conduct tests to ascertain what combination of lysis buffer 
and sonication settings was to be used to shear chromatin to get DNA size fragments in 
the required size range. There are several settings that one can tweak for sonication. 
These include the output power of the sonicator, the duty cycle (the percent on 
time/second of the pulse), the number of pulses per sonication, the wait time after each 
round of sonication and the number of cycles of sonication to use. 
Since there were a high number of parameters to optimize, it seemed unwise to 
begin with the supporting cells of the gonad, as collecting enough cells would be 
extremely time inefficient. Therefore, we used HEK293T cells which could be easily 
cultured, to test out these parameters. The goal with these experiments was to sonicate 
equal numbers of cells (~1M cells) with different settings, reverse the cross-links, purify 
DNA and run gels to evaluate the different size fragments. After attempting several 
different sonication protocols, it was observed that on a Branson sonicator, for HEK293T 
cells, between 8 and 16 cycles of 30s of sonication, followed by 60s of rest time provided 
the required fragmentation. Each sonication was performed at output power 3 with a 
duty cycle of 30%.  
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Varying these settings, several useful observations were made. First, it was 
important to keep the tube on ice while sonicating. In addition, 70% ethanol was added 
to the ice to keep the sonication tube below freezing. Second, using a clamp to hold the 
tube during sonication was important to obtain consistent results. Attempts at manually 
holding the tube at exactly the same height for extended periods of time proved 
extremely difficult. Further, minor movements resulted in the tip probe touching the 
sides of the tube or foaming of the lysate. The use of a clamp allowed sonication to be 
conducted at exactly the same height and position without the need for interference 
from the experimenter after setting up the apparatus. Third, extended periods of 
continuous sonication resulted in foaming of the lysate. This likely was due to over-
heating of the sample.  
We used 16 cycles of sonication at the above settings with C2C12 cells (used for 
optimization of the assay) and discovered that we could achieve fragments of the right 
size as analyzed by an Agilent tapestation (Figure 29). Eventually, the same setting was 
tested first on E17.5 XY supporting cells and then used on the E13.5 XY supporting cells.  
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Figure 29: Fragment size from sonicated C2C12 cells 
100,000 C2C12 cells were sonicated in lysis buffer after cross-linking. Cross-links 
were reversed and DNA was purified. DNA was run on Agilent tapestation. 
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5.3.2 Picking the right cell type for testing 
Ideally, we would have liked to evaluate the various ChIP protocols on the 
supporting cells of the gonad. However, since this would require significant collection of 
material, it would have been extremely time-inefficient. As a result, we attempted to 
identify a cell type that could be used to evaluate the various protocols.  
Several criteria were used to select the cell type for testing ChIP. First, we wanted 
to test our protocols and antibodies against mouse cell lines, as our final samples would 
be from the mouse. This would eliminate any cross species variation in the binding of 
the antibody. Second, we needed a cell type in which we understood the ‘ground truth’ 
situation. This meant access to published ChIP-seq datasets for a number of proteins and 
post-translational modifications, so we could pick regions we knew were going to be 
either enriched or not for the proteins of our interest. With these criteria, we had two 
main candidates – ES cells and C2C12 cells. In choosing between these two cell types, we 
applied our third criteria – the ease and cost of culturing these cells. Since ES cells need 
significant effort to culture, and C2C12 cells are relatively easy, we decided to use C2C12 
as the cells on which we would conduct the tests of the different antibodies and 
protocols. Crucially, genome-wide profiling data existed for this cell type for several 
enhancer correlated marks and proteins including, P300, RNA PolII, H3K4me1 and 
H3K27ac (Asp et al. 2011; Blum et al. 2012).   
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5.3.3 Attempts to use P300 to identify enhancers 
P300 is a ubiquitously expressed histone acetyl transferase that, in addition to 
catalyzing the acetylation of several histone residues including H3K27ac, can acetylate 
residues on several non-histone proteins (Ogryzko et al. 1996; Struhl 1998). While the 
specific mechanism by which this protein has an effect on transcriptional regulation is 
still unclear, it likely involves a combination of being able to facilitate the 
communication between the distal regulatory elements and the promoter and histone 
acetylation functions.  
Despite the lack of understanding regarding the precise mechanism of P300’s 
action, the localization of this co-activator has been used in multiple contexts to discern 
cell-type specific and tissue specific enhancers (Visel et al. 2009; Blow et al. 2010). In one 
excellent validation study, the authors collected ChIP-seq data for P300 from limbs, 
forebrain and midbrain of mice at E11.5 (Visel et al. 2009). They then tested 86 different 
enhancer regions by making lacZ reporter mice. Of these, 87% of embryos were positive 
for enhancer activity specifically in the tissue type where P300 was found to bind the 
region. This is a far higher rate of success in identifying enhancers than has been 
achieved with other methods (Kantorovitz et al. 2009). Additionally, the peaks for P300 
tend to be on the order of a few hundred base pairs which agrees well with size of 
known enhancers. This is in contrast to histone modification marks that are broad 
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kilobase sized regions surrounding the enhancer (Buecker and Wysocka 2012). For these 
reasons, we wished to conduct ChIP-seq with P300 on the supporting cells of the mouse 
gonad.  
Our attempts with P300 ChIP on C2C12 cells were unsuccessful (Figure 30). 
Specifically, we noticed that we were unable to find enrichment for regions that were 
known to be positive from ChIP-seq datasets (Blum et al. 2012). In addition, we observed 
that the enrichment was not significantly greater than what could be observed for 
immunoprecipitation with the IgG control. Increasing the sample amount and the 
antibody concentration showed no improvement.  
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Figure 30: ChIP for P300 in 5M C2C12 cells 
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One possible reason for the failure of this approach could have been that P300 is 
a cofactor that is not tightly bound to the DNA directly. As a result, cross-linking of this 
protein to the DNA was likely highly inefficient. To overcome this, we attempted using 
a double cross-linking method, where proteins are first cross-linked, and this is followed 
by formaldehyde cross-linking to create protein-DNA covalent bonds (Zeng et al. 2006). 
Unfortunately, this method too, showed no improvement in enrichment of P300 binding 
for positive regions over the background. 
After consulting with multiple researchers who have carried out P300 ChIP 
successfully, we learnt that P300 antibody shows considerable variability between 
batches and does not immunoprecipitate large quantities of DNA. This indicated that 
conducting ChIP-seq with small sample quantities would be significantly problematic as 
the amount of DNA retrieved might be too little to build libraries. Therefore, we decided 
to abandon trying to ChIP P300 and attempted to ChIP histone marks correlated with 
active enhancers.  
 
5.3.4 ChIP for histone marks 
Several histone marks have been shown to be correlated with enhancers. Initial 
work identified H3K4me1 as a mark that was enriched particularly in distal enhancers 
as opposed to the promoters of genes (Heintzman et al. 2007). More recently, it was 
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discovered that H3K4me1 marks two classes of enhancers (Creyghton et al. 2010; Rada-
Iglesias et al. 2011). One class is called ‘active’ and these enhancers are expected to be 
participating in driving the expression of downstream genes in the specific cell type. 
These enhancers are seen to have the H3K27ac mark around these regions, likely added 
by P300 or other histone acetyl transferases. The other class of enhancers is called 
‘poised’, and these enhancers are expected to allow for enhancer activity, but are 
currently not participating in driving the expression of downstream genes. These 
enhancers are likely important in the differentiation of the cell to other cell types, or to 
provide the competence to react to extracellular signaling or other environmental 
stimuli. These enhancers do not exhibit the H3K27ac mark.  
We were able to successfully perform ChIP-qPCR with these two histone marks, 
H3K4me1 and H3K27ac, in C2C12 cells (Figure 31). We analyzed published ChIP-seq 
data to pick regions of the genome that should be enriched for these two marks and 
were successful in finding these regions enriched in our ChIP-qPCR experiments (Blum 
et al. 2012). We conducted several iterations of our ChIP experiment, to optimize the 
number of washes and the antibody amounts and were eventually able to produce 
reliable results with 400,000 cells/IP, which is an order of magnitude less than the 
number of cells typically used in ChIP assays.  
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Figure 31: ChIP for H3K27ac and H3K4me1 in ~400K C2C12 cells 
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ChIP for H3K27ac (A) and H3K4me1 (B) with ~400,000 cells/IP was seen to work 
as expected. The different regions used to test the assay are shown in the X-axis. The 
sign in the parentheses indicate if the region was expected to be enriched (+) or not (-). 
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5.3.5 Library preparation and size selection 
A significant hurdle to conducting ChIP-seq with small samples is that the 
amount of DNA in the IP is much lesser than the amount required for building a library 
that can be sequenced. To overcome this, researchers typically perform a whole genome 
amplification of the IP fragments and then use this amplified sample in a library 
preparation (Adli and Bernstein 2011; Ng et al. 2013). More recently, Rubicon’s 
ThruPLEX kit has been used with extremely low amounts of starting material (Sachs et 
al. 2013). We contacted researchers who used this kit and were informed that it was easy 
to use without significant need for optimization. In addition, we analyzed publicly 
available data that had been published by using this kit for library preparation from 
small cell numbers and observed that the data were of a high quality. For these reasons, 
we chose the Rubicon ThruPLEX kit to conduct library preparations. 
We used the input and ChIP samples from C2C12 cells to prepare libraries and 
found that the amount and the size distribution were close to the right size range (Figure 
32). Upon consulting with the sequencing core, we were informed that ideally one 
would prefer a lesser enrichment of the larger size fragments to maximize the number of 
reads obtained from each lane. To do so, we used a SPRI bead size selection, where the 
concentration of the SPRI beads used determines the different size fragments that are 
selected for (DeAngelis et al. 1995). 
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Figure 32: Library Preparation with Rubicon ThruPLEX FD kit for C2C12 cells 
Library preparation for C2C12 cells from input (A), K4me1 (B) and K27ac (C) 
show a size distribution with most fragments between 150-800bp.  
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To optimize the concentration of SPRI beads used, we used a diluted DNA 
ladder. We added SPRI beads of different concentrations, which would bind to the large 
size fragments. The supernatant containing the low size fragments was cleaned using a 
high concentration of SPRI beads. The resulting low size DNA fragments were run on an 
Agilent tapestation and 0.6x was the concentration that was determined to be ideal in 
depleting high fragment sizes while keeping a large fraction of low size fragments. This 
protocol was applied the C2C12 trial library preparation and we observed libraries with 
better size distribution. 
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5.4 Discussion 
The ability to conduct ChIP-seq is a particularly important step towards 
understanding the mechanistic underpinnings of transcriptional regulation in gonadal 
cells. Not only does the development of this assay open doors for identifying enhancers, 
one can use this technique to study several other problems. For example, this can be 
used to localize TFs across the genome as the gonad differentiates. This approach can 
also be used to identify the binding sites of protein complexes such as Polycomb to 
identify genes that are repressed.   
In addition, to the typical challenges involved in conducting ChIP-seq, we had to 
overcome the limitations of the small amount of biological material we were able to 
obtain from embryonic gonads. As a result, we took a methodical approach to 
developing a ChIP assay for the gonad, by attempting several protocols with the C2C12 
cells. Of importance was attempting to use small amounts of C2C12 cells and produce 
reliable and repeatable ChIP-qPCR data. In addition, the ability to prepare libraries from 
small amounts of DNA was a crucial step towards being able to successfully conduct 
ChIP-seq in gonadal cells.  
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6. Identifying active enhancers in XY supporting cells 
6.1 Introduction 
We wished to use the techniques we had developed with human cell lines to 
discover the TFs that play a regulatory role in Sertoli cell differentiation (Natarajan et al. 
2012). Our approach in that study was to use expression data to first identify the cell-
type specifically expressed genes. We have conducted two separate expression studies 
and have a detailed characterization of the genes that are differentially expressed in each 
of the cell types of the gonad (Jameson et al. 2012b; Munger et al. 2013).  
We describe here a pilot study with E15.5 XY supporting cells. Specifically, we 
found that the DNase-seq assay successfully identified several putative regulatory 
regions. These regions show similar properties to those observed in human cell line 
DNase-seq data, indicating that our assay was successful. Further, we observed that 
DHS unique to Sertoli cells were enriched particularly around Sertoli cell specific 
expressed genes. Finally, we identified a previously unknown enhancer of Wt1 by using 
a transient transgenic embryo with a construct expressing LacZ under the control of a 
DHS that we identified in our study. Following this, we collected DNase-seq and ChIP-
seq data for histone marks in E13.5 XY supporting cells to identify active enhancers. In 
addition to identifying the TFs involved in gene regulation, mutations in these distal 
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regulatory regions might also explain the as yet unexplained cases of human sex 
reversal. 
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6.2 Results 
6.2.1 Conducting DNase-seq with E15.5 XY supporting cells 
One of the main impediments to conducting DNase-seq in primary gonadal cells 
was insufficient material. To establish the feasibility of this approach, a previous 
postdoctoral associate in the lab, Danielle Maatouk, in collaboration with Greg 
Crawford, conducted a pilot project with E15.5 XY supporting cells. At this stage, one is 
able to collect more cells than at the earlier E13.5 stage and therefore this expedited the 
process of testing the feasibility of the assay. Specifically, they discovered that they 
could reduce the number of cells required from >10 M cells, to ~5M cells, a significant 
reduction in the number of cells. Crucially, this experiment was successful and ~80,000 
DHSs were identified in the E15.5 supporting cells. To validate the veracity of the data 
we had collected, we characterized a few metrics.  
We first looked to see if the DNase-seq peaks were found in the similar 
proportions in the different regions of the genome and at the right sizes (Figure 33 A, B).  
Crucially, as with the human data, we observed that a majority of DHS peaks (67%) lay 
in intergenic and intronic regions of the genome. There were ~18,000 peaks that 
overlapped promoters of ~13,000 genes. Further, as seen with the human data (Figure 3), 
the peaks overlapping promoter regions where significantly larger than those observed 
at other regions of the genome. In addition, Danielle Maatouk collected RNA-seq data 
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from E15.5 XY supporting cells and we observed a weak correlation between expression 
values and DNase-seq signal at the peak (Figure 33 C, D). Crucially, we observed a large 
variation of expression in genes with peaks at their promoters. This agrees well with our 
previous observation that while the lack of a promoter peak typically implies lack of 
expression, the presence of a peak can lead to a wide variety of expression outcomes.  
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Figure 33: Validation of DNase-seq assay in E15.5 XY supporting cells 
(A) Genomic locations of the DHS peaks. (B) Box plot showing the different sizes 
of peaks by their genomic locations. Promoter overlapping DHS peaks are seen to be 
significantly bigger than other peaks. (C) Expression values from RNA-seq were divided 
into quartiles and the number of genes with and without peaks at their promoters is 
shown. (D) Promoter DHS peaks were divided into quartiles based on the signal 
strength and expression values of the genes in these quartiles as box plots.  
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6.2.2 Unique DHSs are enriched near Sertoli cell specific expressed 
genes 
In order to identify the DHSs that are crucial to drive expression in Sertoli cells, 
we divided the DHS peaks from E15.5 XY supporting cells as follows. By comparing our 
DHS data with data from 6 other cell lines, we asked in how many cell types each DHS 
was open in. Those DHSs that were open in all cell lines were termed common and those 
that were open just the Sertoli cells were termed unique DHS. Those DHSs that were 
open in a subset of cells were termed specific DHS. Figure 34A shows a good example of 
common and unique DHSs. We see that the promoter for Sox9 is open in all cell types 
making it a common DHS. In contrast, the region upstream labeled TESCO, one of the 
few well characterized enhancers in Sertoli cells, is unique to Sertoli cells. This is in good 
agreement with previous work showing that cell-type specific DHSs are enriched for 
enhancers.  
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Figure 34: Sertoli cell unique DHSs are proximal to the Sertoli cell expressed 
genes 
(A) Tracks showing DHSs from different cell types and tissues. The TES and 
TESCO elements were characterized previously (Sekido and Lovell-Badge 2008). This 
region is seen to be unique to Sertoli cells. (B) Different genomic locations of DHS based 
on the number of cell types they are open in. Unique DHSs are depleted for promoter 
DHSs, while common DHSs are enriched for promoter peaks (top panel) and CTCF 
peaks (bottom panel). (C, D) Proximity analysis for genes found enriched and depleted 
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in different cell types in the gonad from a previous study (Jameson et al. 2012b). (C) 
Unique DHSs are found enriched near the Sertoli cell specifically expressed genes and 
also moderately near Granulosa expressed genes compared to all genes. (D) Common 
DHSs do not show significant variation across genes expressed in different cell types. A 
two sided Mann-Whitney test was used to calculate significance. p < 1e-3 (*), p < 1e-15 
(***). 
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We then analyzed the genomic locations of these three different groups of DHSs 
(Figure 34B). Here, we saw a striking difference between the three groups of DHSs with 
the majority of common DHSs being promoter peaks and >70% of them being found in 
genic regions. Interestingly, unique DHSs showed an opposite pattern with <10% being 
present in promoter DHSs. However, > 80% of these peaks are found in regions that are 
typically enriched for cell-type specific enhancer activity such as intergenic and intronic 
regions. We also found that 50% of common DHSs overlap a CTCF site found in ES cells. 
Further, unique DHSs are depleted for these sites.  
A previous study in the Capel lab had investigated the cell-type specific 
expression profiles in different cell types in the gonad at the E13.5 stage (Jameson et al. 
2012b). We enquired whether the chromatin landscape around the Sertoli cell specific 
genes was different from those around genes expressed in other cell types in the gonad. 
We found that while there were a significantly larger number of unique DHS peaks 
around these genes than that found at all genes identified as expressed, we saw no such 
difference for common DHSs (Figure 34 C, D). We further saw that germ cell enriched 
genes showed depletion of unique DHSs and a mild depletion in common DHSs.  
Finally, we wished to confirm that at least a subset of these unique DHSs were 
enhancer regions and tested whether they drove enhancer expression. To do so, we 
picked a unique DHS region upstream of the Wt1 promoter. We cloned this region 
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upstream of an Hsp68-LacZ gene. We made transient transgenic mouse with this 
construct and observed that this region drove expression in Sertoli cells in 6/7 embryos. 
Further, we saw expression in the somatic cells of the ovary in 11/12 embryos, which 
agrees with the expression of Wt1 in both sexes in the early stages. In conclusion, this 
region represents a bona fide enhancer of the Wt1 gene in Sertoli cells. 
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Figure 35: Identification of an enhancer of Wt1 
(A) Several DHSs are observed around the Wt1 locus. The black bars indicate the 
boundaries of the DHS as called by f-seq. A box shows the unique DHS picked for 
testing. (B) A close-up of the DHS picked for testing in the transient transgenic embryo. 
(C) Confocal image showing an E13.5 testis for a transgenic embryo showing expression 
driven by the enhancer construct. (D) shows the zoomed in image of a specific cord 
showing good overlap between Sertoli cells and reporter expression.  
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6.2.3 Identifying regulators from DNase-seq in E13.5 XY supporting 
cells 
We were encouraged by our E15.5 data and went on to assay the chromatin 
landscape in E13.5 XY supporting cells. Our first step was to use our previous approach 
to identifying cell-type specific regulators of gene expression (Natarajan et al. 2012). We 
repeated our analysis of identifying cell-type specific regulators and assigning DHSs to 
them. We then scanned these regions for motifs and used a L1-sparse logistic regression 
classifier to classify male-enriched from female-enriched supporting cell genes. While 
the median AuROC on the human cells lines was ~0.7, our performance on the gonadal 
data was ~0.6. While this performance is clearly better than what is achieved by random 
(0.5), this was not a high enough classification accuracy to confidently identify 
regulators of gene expression in XY supporting cells.  
Therefore, we took a different approach. We identified cell-type specific DHSs as 
we did for the E15.5 data and then set a threshold size of at least 200bp for a region to be 
called a putative enhancer. We repeated this analysis for the other cell types and 
identified putative enhancers in these cell types too. We then scanned these regions for 
all known motifs and used the L1-sparse logistic regression classifier. Upon doing this 
analysis, we found a significantly better performance in our classification with an 
AuROC of ~0.88. However, despite this increased performance, as before, due to high 
numbers of TFs belonging to same family being represented in the data, we were unable 
 188 
 
to identify the specific TFs that were important in regulating gene expression. We then 
reduced the set of TFs to those that are either known to be important in sex 
determination and those that were identified in our fine time course expression profiling 
study (Munger et al. 2013). This analysis resulted in an AuROC of 0.82. Specifically, we 
identified that some of these TFs are likely important in sex determination and are 
bound in Sertoli cell specific open regions (Figure 36). Of these, Etv4/5 is particularly 
interesting as it is known to be downstream of FGF signaling (Zhang et al. 2009).  
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Figure 36: Factors identified by motif analysis of Sertoli specific DHS 
The TFs important in sex determination from previous literature are shown in 
the left column of TFs. The TFs identified in our motif analysis data are outlined in the 
box. The TFs discovered from our study (Munger et al. 2013) are shown in the colored 
boxes. TFs identified in our motif analysis our indicated by an arrow.  
 190 
 
6.2.4 ChIP-seq for H3K27ac in E13.5 XY supporting cells 
To identify the active enhancers in E13.5 XY supporting cells, we attempted to 
conduct ChIP-seq for H3K4me1 and H3K27ac. Unfortunately, our H3K4me1 data 
showed high levels of background and low levels of correlation between replicates. 
However, our K27ac data showed high signal compared to background and a 
correlation of 0.89 between replicate tracks. Further, we found that >22,000 peaks were 
found in each replicate, with ~16,000 peaks common between replicates. Several of these 
peaks are around genes important in Sertoli cell differentiation. For example, at the 
Gata4 locus, we saw several peak marks overlap Sertoli cell-specific DHS (Figure 37A). 
We then conducted a preliminary characterization of the K27ac peaks by 
comparing it to the DHS peaks from multiple cell types. Crucially, we observed that the 
K27ac peaks are enriched specifically in DHS from Sertoli cells (Figure 37B). Further, the 
reciprocal analysis of analyzing the DHS from different cell types showed that while the 
cell-type specific DHS show enrichment for Sertoli cells, we did not see this enrichment 
for ubiquitous DHS peaks (Figure 37C).  
We are currently conducting further analysis with the K27ac peaks to identify 
motifs that differentiate active enhancers from cell-type specific DHSs.  
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Figure 37: H3K27ac identifies active enhancers in E13.5 XY supporting cells 
(A) Genomic locus (chr14:63,852,125-63,977,501) showing the region around 
Gata4. Several Sertoli specific peaks are observed around the gene. Further, several of 
these peaks overlap K27ac peaks in both replicates. (B) Overlap of histone peaks with 
DHS data from different cell lines. Sertoli-cell specific DHS have an enrichment of K27ac 
peak overlaps. (C) Based on overlap with DHS in other cell types, each DHS is classified 
as open in a specific number of cell types. Compared to other cell types, Sertoli-cell 
specific DHSs show higher overlap with the histone peak marks. However, the 
ubiquitous DHSs show equal overlap across all cell types.  
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6.3 Discussion 
The work described here presents an initial attempt at characterizing the 
chromatin landscape in E15.5 and E13.5 XY supporting cells. While most experiments 
that profile genome-wide enhancers require > 10M cells, this was accomplished here 
with ~5M cells. This represents a significant advance and makes this approach useful in 
other developmental systems. Further, our initial analysis showed that by several 
metrics such as genomic location and size of DHS, our DNase-seq data show similar 
characteristics to the data from human cell lines and other cell types very well. This 
indicates that our attempts were indeed successful in profiling the chromatin landscape 
in this cell type. We also identified that the DHSs unique to Sertoli cells were enriched 
near Sertoli cell specific expressed genes. We used this data to identify an enhancer 
upstream of Wt1 driving reporter expression. In addition, we conducted motif analysis 
on the Sertoli cell specific DHSs and found novel TFs that are likely involved in the 
differentiation process. Finally, we collected ChIP-seq data for H3K27ac and found that 
these peaks are enriched for overlap with Sertoli cell specific DHS.  
It must be noted that our work here is still in progress and is a preliminary 
attempt at delving into the question of chromatin landscape in this cell type. We are 
currently working on conducting a more in-depth motif analysis and incorporating our 
ChIP-seq data set for H3K27ac into our analysis.  
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7. Conclusions 
It is somewhat surprising and fortuitous that the different projects that I have 
participated in have come together in a cohesive framework.  
In the first project described here, we worked with DNase-seq and expression 
data collected by the Crawford lab from several human cell lines (Natarajan et al. 2012). 
With an eye towards data that would eventually be collected from gonadal cells, we set 
ourselves the task of trying to predict cell-type specific expression in this wide panel of 
human cell lines. Crucially, this would allow us to also identify novel regulators in these 
cell types. We first found that the chromatin architecture at the TSS of these genes did 
not change significantly between cell types and if they did, it was at a specific subset of 
genes showing cell-type specific up-regulation. We then looked at whether sequence 
features in regions of open chromatin were more informative of the genes that were 
regulated in specific cell types than the information in the proximal promoter.  
Importantly, across every classification task we set, we observed far better performance 
when we used information from the putative distal regulatory elements identified by 
DNase-seq. The regression coefficients in our logistic regression model also suggested 
the activating or repressive roles of the TFs that were identified as informative. Our 
models identified known and novel TFs that likely play important regulatory roles in the 
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cell types we studied. Finally, at least some of these TFs showed cell-type specific 
footprints in the cell types where they were predicted to be functional.  
In attempting a similar approach for the gonad, we first needed to collect 
accurate and detailed transcriptional information during the differentiation of the 
gonad. We conducted two experiments to perform this characterization of the 
differentiation process. In a work not discussed in this thesis, we analyzed expression 
data from different cell types in the gonad during the window of sex determination 
(Jameson et al. 2012b). The second project, described in this thesis, dealt with a fine time-
course dataset collected from XX and XY gonads at multiple time points in a one-day 
interval from E11.0-E12.0 from two strains of mice (Munger et al. 2013). We designed an 
HMM that was specifically suited to the task of identifying cascades of transcriptional 
regulation. We discovered 5 cascades of regulation that generated hypotheses regarding 
the upstream regulators of sex determination. Interestingly, while the male-enriched 
genes show a strong pattern of up-regulation in XY gonads, female-enriched genes are 
down-regulated in the XY gonad. This indicates that in addition to an activating 
program, the testis has a repressive program that results in down-regulation. Further, 
since the ovary is, for the most part, maintaining the existing transcriptional state, it has 
a transcriptome that is highly similar to the bipotential gonad. This is particularly 
interesting as it poses questions regarding how minor transcriptional changes can 
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govern the commitment potential of the organ. Finally, this might also be a means for 
the gonad to ensure that it picks one of two different fates. 
Additionally, we looked at this differentiation process in two strains of mouse – 
the B6 strain which is susceptible to sex reversal and the 129S1 strain which is more 
robust. The striking difference we observed between the transcriptomes of these two 
strains of mouse was the delay in the initiation of the male pathway in the B6 strain of 
mouse. Given the importance of timing in sex determination (Hiramatsu et al. 2009), this 
difference is likely to be a cause of the increased susceptibility to sex reversal in B6 mice. 
In addition, we integrated this data with eQTL data collected in a previous study 
(Munger et al. 2009) to pick candidate regulators of sex determination. We identified 
Lmo4 as a good candidate and proceeded to knock it down in an in vitro RNAi assay 
with primary gonadal cells. This resulted in the down-regulation of several male-
enriched genes, indicating we have discovered a novel regulator of sex determination.  
Once we characterized the transcriptional differences, we collected DNase-seq 
data from E13.5 XY supporting cells. In addition, we developed techniques to perform 
ChIP-seq from low numbers of cells. We collected ChIP-seq data for H3K27ac, the 
histone mark correlated with active enhancer status, from XY supporting cells. 
Combining these two types of data we identified putative active enhancers in the XY 
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supporting cells. We also conducted motif analysis to identify the sequence features that 
are enriched in Sertoli cell specific DHSs. 
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8. Future Directions 
It is, to my mind, very exciting that there are several possible future directions 
that one could take in moving forward with the work described in this thesis. While we 
have made significant progress in using genome-wide enhancer identification to identify 
important regulators in different cell types, applying these methods to uncover the TF 
network in mammalian sex determination, and developing techniques such as ChIP-seq 
with limited sample quantity, in every one of these endeavors one can see crucial 
improvements and future studies that need to be carried out.  
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8.1 Improving predictive models of gene expression 
Clearly, genome-wide enhancer identification approaches such as DNase-seq, 
ChIP-seq and FAIRE-seq have moved us forward by leaps and bounds to understand 
the global chromatin configuration and they give us an extremely informative view of 
where TFs are bound. However, there are two additional improvements that one can 
foresee that will improve predictive models of gene expression.  
The first of these, DNase footprinting, has been moving rapidly towards better 
predictions of TF binding from DNase-seq data. DNase footprinting has been used for 
more than 3 decades to identify sequences that are bound by TFs, but recent work has 
attempted to computationally glean these footprints on a genome-wide scale (Galas and 
Schmitz 1978; Boyle et al. 2011; Pique-Regi et al. 2011; Neph et al. 2012). Specifically, 
while some factors such as NRSF and CTCF form well defined footprints, other factors 
are not so pronounced in their footprints. Furthermore, DNaseI seems to have a limited, 
but not insignificant, sequence bias that has to be accounted for when one tries to 
identify binding sites of TFs (Koohy et al. 2013; He et al. 2014). This is particularly 
problematic when the TF in question has a motif that is affected by the DNaseI sequence 
bias. Nonetheless, recent techniques, including those being developed in the Ohler lab, 
are beginning to account for this and improve the accuracy with which one can identify 
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occupied TFBSs in DNase-seq peaks (He et al. 2014; Sherwood et al. 2014). Progress in 
this front will improve predictive models of gene expression.  
Another key improvement is likely to be in identifying the interactions between 
specific enhancers and genes. Given that enhancers do not interact with genes in a 
manner determined by linear distance, our use of proximity as a proxy for interaction is 
an over-simplification (Sanyal et al. 2012; Jin et al. 2013). The experimental techniques 
most pertinent to addressing this issue are the suite of chromosome conformation 
capture techniques such as 3C, 4C, 5C and Hi-C (de Wit and de Laat 2012). These 
techniques are typically limited by their lack of resolution, although one recent study 
reported a resolution of approximately 5-10kb (Jin et al. 2013). This level of resolution 
will be particularly useful in understanding which enhancers interact with which 
promoters. Another experimental approach that is beneficial to identify enhancer 
promoter interactions is ChIA-PET or Chromatin Interaction Analysis by Paired-End 
Tag sequencing, which identifies proteins that are concurrently proximal to multiple 
regions of the genome (Fullwood et al. 2009). This technique was recently used with a 
PolII IP, resulting in a high resolution interactome map of the transcribed regions of the 
genome (Kieffer-Kwon et al. 2013). Similar assays can be carried out under conditions of 
environmental stimuli, for example, to understand the dynamics of chromosome 
conformation during gene expression changes.  
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Alternatively, computational and data analysis techniques can be used to 
identify putative interactions. Recent work has used DNase-seq data across several cell 
lines, to identify cell-type specific DHSs with expression changes of genes in cis 
(Sheffield et al. 2013). Similar approaches have been used with data from chromatin 
marks and PolII ChIP (Akhtar-Zaidi et al. 2012; Shen et al. 2012). While one can identify 
several enhancer-promoter interactions in this way, the need for data from several cell 
lines makes this a less than ideal approach. Recent work in the Ohler lab, attempts to 
circumvent this by jointly learning both the factors that regulate gene expression and the 
regions of the genome where these TFs bind near the genes that show cell-type specific 
expression patterns. This is a promising approach that might reveal the principles of 
enhancer-promoter interactions.  
Taken from a longer perspective, the problem of how enhancers communicate 
with promoters is one of central importance in mammalian gene regulation (Krivega 
and Dean 2012). Therefore, one might want to step back and instead of trying to predict 
gene expression, attempt to predict the chromosome conformation gleaned from 
experimental assays. Recent data indicates that topological domains are organized by 
CTCF, cohesin and lamins (Lund et al. 2013; Baranello et al. 2014; Collas et al. 2014). 
Using this data, and associated chromatin marks (H3K9me3, in particular) to model 
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chromosome conformation would be an extremely useful advance to understanding 
gene regulation. 
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8.2 Transcriptional changes and their causes in the supporting 
cells 
Our work here has helped us move significantly closer to understanding the 
transcriptional behavior and the factors at play in supporting cells, particularly XY 
supporting cells. However, it has also generated several immediate questions.  
First among these is which factors mediate the down-regulation of the female-
enriched genes in the male gonad. While we knew that a few genes were down-
regulated, we did not envision that hundreds of genes would show this trend. It remains 
to be seen whether all these genes are each independently repressed by a large network, 
or if only an activator of female-enriched genes is actively repressed, resulting in the 
consequent down-regulation of several of these genes. One hypothesis is that this 
repression is mediated by the polycomb complex. This is particularly interesting because 
the polycomb component, Cbx2, is known to be important for male development (Katoh-
Fukui et al. 1998; Katoh-Fukui et al. 2012). Current experiments in the Capel lab are 
focused on identifying the binding locations of the polycomb factor, Ring1b, in XY 
supporting cells. These experiments could be highly informative about the mechanism 
of the repression. However, it must be kept in mind that while polycomb is in general an 
attractive candidate for repression, it must be recruited to a specific locus 
(Schuettengruber and Cavalli 2009). Therefore, even if polycomb is involved in the 
 203 
 
repression of female-enriched genes, key questions will still remain about the factor that 
provides the specificity for these genes to be repressed.  
Second, while we successfully identified the onset of the male program, our time-
course of expression did not identify the onset of the genes in the bipotential gonad. This 
is particularly important given that the early differentiated ovary (E12.0) is very similar 
to the bipotential gonad. Therefore, we are not only missing out on the transcriptional 
cascades that give rise to the bipotential gonad, but also the genes that are eventually 
female-enriched. One way to approach this problem is to profile the expression at a fine 
time granularity at earlier stages (~E10.5). This can be done in a sorted cell population 
from cells that can be obtained from the Sf1-EGFP mouse (Nef et al. 2005). These cells are 
expected to be, for the most part, bipotential supporting cells that will eventually 
express SRY.  This approach could also be informative regarding the transcriptional 
dynamics in the gonad prior to the expression of Sry. It is important to note that, apart 
from genes on the Y-chromosome, and some genes on the X-chromosome, there will be 
no expression differences between XX and XY gonads. Therefore, to identify cascades, 
the HMM would have to be tweaked to monitor temporal changes between adjacent 
time points.  
Third, a major question opened up by previous studies is how the critical 
window of sex determination is kept open for the initiation of the male pathway 
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(Hiramatsu et al. 2009). Specifically, it has been noticed that the timing of Sry activation 
is tightly regulated to a 6 hour time period, which if missed, will result in ovarian 
development. Our time course transcriptome, while suggesting possible genes involved 
in implementing this behavior, also adds a level of intrigue to it. Namely, given that the 
transcriptome of the bipotential gonad and the ovary are highly similar, how do the 
minor changes observed allow the bipotential gonad to activate the male program while 
impairing this ability in the early differentiated ovary. Of the few genes that show 
dynamic changes in expression, a TF that is strongly up-regulated in XX gonads at E11.6 
is Irx3 (Munger et al. 2013). While the mutant for this gene has not shown a striking 
embryonic phenotype (Jorgensen and Gao 2005; Kim et al. 2011), I would argue that the 
experiments conducted do not test the specific hypothesis that Irx3 is the gene that 
regulates the window of male pathway activation by Sry. Two experiments can be 
conducted to test this hypothesis. One experiment would entail using an XX Irx3-/- 
embryo that also has an Hsp-Sry transgene (Hiramatsu et al. 2009). If the hypothesis that 
Irx3 regulates the window of sex determination is true, it follows that removing Irx3 
should extend the window of potential male pathway activation. Therefore, delayed 
activation of Sry by heat shock should still result in testis development. Alternatively, 
one could attempt to ectopically express Irx3 in XY gonads and observe if the male 
pathway can be initiated. 
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8.3 The TF network in multiple cell types in the gonad 
The majority of our success has been in understanding the transcriptional 
dynamics and their causes in the XY supporting cells of the gonad. Due to technical 
difficulties, including obtaining sufficient biological material, we were unable to glean 
similar information from XX supporting cells. For similar reasons, we did not attempt to 
collect data from the bipotential supporting cell precursors. An understanding of these 
two cell types will be crucial to improving our knowledge of how chromatin can allow 
for potential in precursor cells and then proceed to shut down this potential as 
differentiation progresses.  
There are good reasons to hope that the technical difficulties will not be 
insurmountable in the near future. Chief among these reasons, is the development of a 
new protocol named ATAC-seq, or Assay for Transposase-Accessible Chromatin using 
sequencing (Buenrostro et al. 2013). In this technique, fresh cells are collected, nuclei are 
isolated, following which a transposase is introduced. This transposase, which can only 
access regions of open chromatin, inserts an adapter at these sites which are then used to 
build a library. The protocol has been optimized to work at ~50,000 cells, two orders of 
magnitude less than the 5 million cells needed for DNase-seq. This technological 
advance opens the door to understanding the chromatin landscape of the XX 
differentiated cells and the early bipotential cells. As for improvements in ChIP-seq, we 
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tried to perform ChIP-seq with ~40,000 cells/IP with XX supporting cells, but were not 
successful. Given this was a first attempt, if resources are invested to optimize the small 
cell number assay, we will likely be able to obtain useful and illuminating data in these 
cell types.  
Another level of detail that we have ignored in our study is that supporting cells 
are derived from cells in the coelomic epithelium (Karl and Capel 1998). Interestingly, 
these cells seem to be the precursor cells for at least one other cell type, called the 
interstitial cells. Therefore, in addition to the sexual fate decision that we have been 
concerned with, the supporting cells have had to already differentiate themselves from 
the interstitial cells. It has been hard to penetrate how they make this decision, due to 
the difficulties in sorting the cells of the coelomic epithelium. Nonetheless, we can sort 
supporting cells and interstitial cells in the E13.5 gonad and look for differences in the 
chromatin between these two cell types. This too would be an effective and potentially 
less challenging means of understanding how cell fate decisions are made. 
The supporting cells serve as a fantastic model for bipotential cells which arise in 
a variety of developmental systems. However, the unique property of the gonad is that 
the whole organ is bipotential, with multiple cell types concurrently committing to one 
of two different fates. This situation is unique in organogenesis and the bipotentiality of 
the early gonad primordium is conserved across vertebrates (Barske and Capel 2008). 
 207 
 
How such a decision is implemented in the chromatin of multiple cells is a fascinating 
question that can only be approached by research in the gonad. The mouse gonad is 
ideally suited to this problem, due to the development of multiple transgenic lines of 
mice that enable the sorting of distinct cell populations at various stages of their 
development. One can study how the existing chromatin environment allows the germ 
cells and interstitial cells to respond to the signaling from the supporting cells. The 
motifs in the cell-type specifically enriched enhancers will likely indicate which 
extracellular signaling pathways are operative in each of these cell types. Comparisons 
between XX and XY cells will reveal the sex-specific signals responsible for the sexual 
dimorphism of these cell types. If I had a few more years in graduate school, these 
fascinating questions would fully occupy my time. 
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